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Abstract 
Complex and unique enzymology is often behind the biosynthesis of natural 
products.  This thesis is focused on how non-proteinogenic amino acids are 
biosynthesized and then incorporated into natural products.  Chapters two, three and four 
deal with a unique dioxygenase found in vancomycin biosynthesis.  Chapter five 
elaborates on the biochemical characterization along with efforts toward structural 
characterization of a terminal non-ribosomal peptide synthetase module. 
The vancomycin biosynthetic enzyme DpgC belongs to a small class of 
oxygenation enzymes that are not dependent on an accessory cofactor or metal ion.   The 
detailed mechanism of cofactor-independent oxygenases has not been established.   We 
have solved the first structure of an enzyme of this oxygenase class complexed with a 
bound substrate mimic.  The use of a designed, synthetic substrate analog allows unique 
insights into the chemistry of oxygen activation.  The structure confirms the absence of 
cofactors, and electron density consistent with molecular oxygen is present adjacent to 
the site of oxidation on the substrate.  Molecular oxygen is bound in a small hydrophobic 
pocket and the substrate provides the reducing power to activate oxygen for downstream 
chemical steps.  Our results resolve the unique and complex chemistry of DpgC, a key 
enzyme in the biosynthetic pathway of an important class of antibiotics. Mechanistic 
parallels exist between DpgC and cofactor-dependent flavoenzymes, providing 
information regarding the general mechanism of enzymatic oxygen activation. 
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Introduction 
 Vancomycin was originally isolated in the 1950s from soil samples found in 
Borneo.1 Several members of this family of antibiotics from Amycolatopsis and 
Streptomyces strains have been isolated and structurally characterized.2 Their complex 
molecular architecture has made this family of natural products of longstanding interest 
to both biosynthetic and synthetic chemistry efforts.3,4,5 
 
The vancomycin family of clinically important antibiotics are peptide based 
natural products commonly referred to as a “last resort” when treating life-threatening 
infections of gram-positive bacteria.6   This family of antibiotics targets cell wall 
Vancomycin 
Amycolatopsis orientalis 
Teicoplanin 
Actinoplanes teichomyceticus 
 Chloroeremomycin 
Amycolatopsis orientalis 
 Balhimycin 
Amycolatopsis mediterranei 
Figure 1:  Vancomycin and teicoplanin family members, and their producing organism.  
  2 
biosynthesis through binding the D-Ala-D-Ala precursor of the growing peptidoglycan 
layer of the bacterial cell wall (Figure 2).7 At its core vancomycin is a heptapeptide 
scaffold produced by a nonribosomal peptide synthetase (NRPS).8 This scaffold 
undergoes extensive modification to give the mature natural product its potent biological 
activity.  The key modifications to the peptide scaffold are the one aryl and two aryl ether 
cross-links that create the cup-like shape of vancomycin.9 This rigidification allows 
vancomycin to sequester the D-Ala-D-Ala precursor, thereby preventing bacterial cell 
wall biosynthesis.  Vancomycin family members are also ornamented with sugar moieties 
at the 4-OH-PheGly4 position, as well as the β-OH-Tyr6 position in some family 
members (Figure 1).5   
Most bacteria that produce small molecule antibiotics as chemical warfare agents 
in the battle for survival have a self-protection and immunity mechanism against their 
own antibiotics.10 In the case of the vancomycin family producer organisms, self-
protection comes from a mutation of the D-Ala-D-Ala cell wall precursor to a D-Ala-D-
Lac moiety.  It is thought that the source of resistance found in pathogenic Enterococci 
comes from the three genes found in the producing organisms that protect against 
Figure 2:  Vancomycin in complex with D-Ala-D-Ala (left), a space-filling model (right).  
  3 
vancomycin.11 Of the three resistance-conferring enzymes, VanH forms D-lactate from 
pyruvate, while DdlM couples D-lactate to D-alanine.  The third enzyme, VanX, 
hydrolyzes D-Ala-D-Ala, making D-Ala-D-Lac 
a more readily abundant metabolite for cell wall 
biosynthesis.12 The incorporation of a lactate 
moiety not only creates a loss of one hydrogen 
bond between vancomycin and the cell wall 
precursor; it also creates repulsion between a 
carbonyl in the vancomycin backbone and the 
ester oxygen in D-Ala-D-Lac (Figure 3).  The 
rise of vancomycin-resistant Enterococci 
(VRE) has made the biosynthesis of this antibiotic family of particular interest.  
Producing vancomycin analogs holds great potential for overcoming resistance in VRE.13 
Through better understanding nature’s method of synthesizing these complex natural 
products, a facile route toward analog synthesis could be developed.  
 
Nonribosomal peptide synthetases:  Synthesis of the vancomycin heptapeptide 
At the center of the vancomycin biosynthetic pathway are multidomain 
nonribosomal peptide synthetases (NRPS).  These systems are organized into  
modules responsible for activation and incorporation of amino acid monomers (Figure 
4).14  
Figure 3:  Vancomycin interacting with D-
Ala-D-Lac 
  4 
 
Each module is made up of domains, individually folded proteins covalently attached to 
each other via linker regions.  Each domain carries out a different aspect of constructing 
the vancomycin scaffold.  Adenylation (A) domains activate specific amino acids by 
forming an aminoacyl-AMP, then transferring the aminoacyl group to a peptidyl carrier 
protein (PCP) equipped with a phosphopantetheinyl arm (Figure 5).  The newly formed 
thioester bond then acts as an electrophile for the subsequent coupling reaction carried 
out by a condensation (C) domain.  Seven A domains activate the distinct amino acid 
monomers that are coupled via amide bonds to form the heptapeptide scaffold.  These A 
domains are in a co-linear sequence in the gene cluster corresponding to the order of 
Figure 4:  A schematic representation of the vancomycin non-ribosomal peptide synthetase (NRPS) 
assembly-line 
  5 
amino acids in vancomycin.  After each amino acid is loaded onto the synthetase, six C 
domains in the vancomycin pathway form the six peptide bonds.15   
Not all NRPS systems have an even ratio between C domains and bonds formed 
by the assembly-line; one such case is discussed in Chapter 5 of this thesis.16 Once a C 
domain makes a peptide bond, the growing peptide chain is passed down the assembly 
line to the following PCP domains.  The final NRPS module contains a thioesterase (TE) 
domain, which cleaves the completed peptide scaffold from the NRPS assembly line. 
Efforts towards engineering these systems have focused on exploiting the 
assembly-line nature of NRPS, and alteration of the glycosyl groups decorating 
vancomycin.  Attaching a biphenyl group to the sugar moiety in the natural product 
Figure 5:  Activation and tethering of amino acids on the NRPS assembly-line; the chemistry of the 
adenylation (A) and peptidyl carrier (PCP) domains   
  6 
overcame resistance in vancomycin resistant enterococci (Figure 6).17 The Kahne group 
demonstrated that this analog was not binding the D-Ala-D-Lac cell wall precursor, 
instead targeting bacterial transglycosylases.18 These findings show that altering the 
vancomycin scaffold can lead to antibiotic function outside the typical mode of action for 
vancomycin.  Study and manipulation 
of the biosynthetic pathway can 
potentially lead to overcoming 
resistance through unexpected means.  
The Liu group demonstrated that altered 
A domain specificity can be achieved 
through directed evolution.19 By 
controlling which amino acid monomers 
A domains activate, this technique 
expands monomers available for incorporation by the NRPS system at various positions 
on the heptapeptide.  By incorporating a variety of monomers at a selected position, 
biosynthesis of analogs could become quite facile.20 This expansion of heptapeptide 
diversity makes the study of nonproteinogenic amino acids crucial to vancomycin analog 
biosynthesis. 
NRPS systems incorporate over 300 amino acids to achieve a wide variety of 
peptide scaffolds, leading to a large structural diversity in peptide natural products.  The 
biosynthesis of such building blocks is another interesting and complex aspect of 
vancomycin biosynthesis.   
 
Figure 6:  Chlorobiphenyl vancomycin; effective 
against VRE 
  7 
Biosynthesis of the nonproteinogenic amino acid (S)-3,5-dihydroxyphenylglycine, 
Dpg  
The nonproteinogenic amino acid (S)-3,5-dihydroxyphenylglycine (Dpg) is 
incorporated at the seventh position in vancomycin family members and at the third and 
seventh positions in teicoplanin (Figure 1 and 7).21 Unlike many nonproteinogenic amino 
acids found in natural products,22 Dpg is not derived from the pool of 20 canonical amino 
acids.  The biosynthesis of this amino acid is of 
particular importance due to the flexibility of 
the vancomycin biosynthetic pathway towards 
incorporating analogs into the seventh position.  
The Sussmuth group showed that supplementing 
a DpgA knockout mutant, which cannot produce 
Dpg, with various phenylacetic acid derivatives 
leads to the generation of novel glycopeptides 
through substitution at the seventh position.23 
Since vancomycin analogs are known to have alternate antibiotic function and because of 
the plasticity at the seventh position, the pathway toward Dpg is of particular interest for 
many combinatorial biosynthesis efforts. 
The biosynthetic gene clusters of the vancomycin family contain five enzymes 
involved in the biosynthesis of the amino acid Dpg.  Elucidation of this pathway began 
with feeding experiments and culminated in biochemical characterization of all five 
enzymes.  By supplementing fermentation of Amycolatopsis orientalis with (1,2-
13C)acetate, the Williams lab initially showed the source of the Dpg carbon skeleton is 
Figure 7:  Vancomycin with Dpg, at the 
seventh position, highlighted 
  8 
derived from four acetate units.24 This is in contrast to other nonproteinogenic amino 
acids in vancomycin and other non-ribosomal peptides, which are derived from 
proteinogenic amino acids like tyrosine.  Additional feeding experiments were carried out 
in an effort to determine the intermediates of the Dpg pathway.  It was shown that 
addition of 13C labeled dihydroxyphenylacetic acid (1) and dihydroxymandelic acid (2) 
led to incorporation of these precursors into chloroeremomycin.25 Based on this evidence 
and the putative assignment of open reading frames (ORF) in the gene cluster, the 
pathway shown in Figure 8 was proposed.  Although this pathway does not resemble 
what we now know as the Dpg biosynthetic pathway, it is not totally unreasonable.  
Assuming that 2 and 3 are precursors to vancomycin, the ORFs selected to complete the 
biosynthesis of Dpg were logical selections.  CepL, previously designated Orf20, is a 
heme dependent monooxygenase, which hydroxylates the benzyl position of L-Tyr to 
make β-hydroxytyrosine.  In the Williams group proposal, CepL catalyzes a homologous 
reaction. However this transformation is unlikely as the actual substrate of CepL is 
tethered to a peptidyl carrier protein via a phosphopantetheine linker.  (CepL is discussed 
in greater detail in the appendix of this thesis.)  Unpublished data from the Williams 
group shows the FMN dependent oxidase Hmo, found in all vancomycin pathways, does 
in fact oxidize 2 to 3. The final proposed step implicates the aminotransferase HpgT in 
Figure 8:  Dpg biosynthetic pathway proposed by the Williams group  
  9 
the amination of the glyoxylate; this step has been corroborated by subsequent research.  
A more likely explanation for the incorporation of 13C labeled dihydroxyphenylacetic 
acid (1) is the action of a promiscuous CoA-ligase that couples 1 to CoA.  This substrate 
would then follow the accepted pathway to Dpg.  The incorporation of 2 may actually 
follow the proposed pathway, however this is not a naturally occurring pathway to Dpg.  
This work did identify Orf27, now called DpgA, as a chalcone synthase homolog, part of 
the Type III polyketide synthase (PKS) family, which couples four units of malonyl-CoA 
in the first step toward Dpg (Figure 9). 
The Pelzer group confirmed that DpgA is in fact a Type III PKS responsible for 
the synthesis of a Dpg precursor.26 Before exploration of the Dpg pathway, only one 
Figure 9:  Proposed in vivo function of DpgA 
Figure 10:  Dpg biosynthetic pathway proposed by the Pelzer group 
  10 
Type III PKS had been indentified in prokaryotes.27 The Pelzer group sought to 
characterize the Dpg pathway through genetic and biochemical studies.  A deletion 
mutant of the dpgA gene in the producing organism, A. mediterranei, lacked the ability to 
produce the biologically active compound.  Production of the antibiotic was restored to 
the mutant bacteria through addition of dihydroxyphenylacetic acid.  Upon heterologous 
expression of DpgA in Streptomyces lividans, dihydroxyphenylacetic acid was produced.  
In vitro characterization of DpgA showed the production of dihydroxyphenylacetic acid 
exclusively from malonyl-CoA.  Co-expression of DpgA, B, C and D in Streptomyces 
lividans led to production of dihydroxyphenylglyoxylate.  Based on sequence homology 
the Pelzer group suggested that DpgB and D were involved in isomeration of the DpgA 
product while DpgC may possess dehydrogenase activity.  A detailed biosynthetic 
pathway was proposed by the Pelzer group based on their characterization of DpgA and 
alignment studies of DpgB-D (Figure 10). The four enzymes, DpgA, DpgB, DpgC and 
DpgD, are translationally coupled with dpgA the beginning of the operon.  DpgA-D have 
sequence similarity to enzymes that use coenzyme A derivatives as substrates, leading to 
the conclusion that the pathway is carried out on CoA derivatives as opposed to free 
acids.  Therefore, it is interesting that the Pelzer group concluded the product of DpgA to 
be a free acid.  The Pelzer group also analyzed a knockout of the aminotransferase HpgT.  
The HpgT knockout did not produce the antibiotically active compound.  The pathway 
was only reconstituted through addition of both 4-hydroxyphenylglycine (Hpg) and 3,5-
dihydroxyphenylglycine (Dpg), showing the use of HpgT in both amino acid pathways.  
This work offered insight into the function of DpgA.  However biochemical analysis of 
the pathway was incomplete, leaving the proposed pathway open to interpretation.   
  11 
The Walsh lab described the activity of the enzymes DpgA-D through 
heterologous expression in E. coli and in vitro biochemical characterization.28 The 
function of DpgA was properly assigned through incubation with malonyl-CoA, which 
resulted in formation of dihydroxyphenylacetyl-CoA (Dpa-CoA) as detected by HPLC 
analysis.  The rate of reaction of DpgA was very slow and required overnight incubations 
to detect any product.  Upon addition of DpgB, a 17-fold increase in rate was detected, 
although DpgB alone has no detectable reactivity towards 
malonyl-CoA.  When DpgD was added to the DpgA/B 
mixture, a further 2-fold increase was observed in the 
production of Dpa-CoA.  A DpgA/D mixture did not result in any rate increase over the 
DpgA rate.  Bioinformatic analysis of DpgB and DpgD showed that they had high 
similarities to the crotonase superfamily.  Hydratase activity, common in the crotonase 
 
Figure 11:  Reactions catalyzed by the enzymes DpgA, DpgB/D and DpgC proposed by the Walsh 
group 
Figure 12:  Enoyl-CoA 
hydratase (crotonase) 
activity 
  12 
superfamily (Figure 12), was detected when DpgB and DpgD were incubated with 
crotonyl- and β-methylcrotonyl-CoA.  Due to the rate enhancement DpgB and DpgD 
demonstrate, they could possibly form a complex with DpgA.  Details on how these 
crotonase family enzymes accelerate the rate of Dpa-CoA production are yet to be 
resolved.   
 This initial publication on the Dpg pathway also included some characterization 
of the enzyme DpgC.  The unknown function of this unusual enzyme was largely 
responsible for the limited understanding of Dpg biosynthesis. The Walsh group 
demonstrated the enzyme DpgC oxidizes the α−C methylene to a ketone and cleaves the 
thioester of Dpa-CoA to release dihydroxyphenylglyoxylate and CoA (Figure 11).  Three 
separate enzymes typically carry out this transformation:  flavoprotein desaturase, 
crotonyl-type enoyl thioester hydratase and an alcohol dehydrogenase.  These initial 
results warranted further study of DpgC by the Walsh group, discussed in the next 
section. 
 
The cofactor-independent dioxygenase DpgC 
As discussed above, DpgC performs a four-electron oxidation and cleaves a 
thioester bond (Figure 11).  Detailed biochemical characterization of DpgC demonstrated 
it catalyzes this unique oxidation chemistry using only molecular oxygen and the 
substrate.   The absence of any cofactor or metal puts DpgC in a very small subset of 
oxygenases, which makes it a fascinating target for study by mechanistic enzymology. 
Bioinformatic analysis of DpgC indicated the C-terminal two-thirds of the 
enzyme is homologous to crotonase superfamily members.  It is interesting that the 
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pathway to Dpg contains enzymes involved in cyclization and in oxygenation that are all 
members of the same enzyme superfamily.  Additional examples of oxygenases and 
cyclases from the same biosynthetic pathway arising from similar protein scaffolds are 
discussed later in this chapter. 
Labeling studies with 18O established that DpgC incorporates both oxygen atoms 
from molecular oxygen into the glyoxylate product.29 Enzyme activity was shown to be 
dependent only on the presence of O2 and no turnover was observed under an argon 
atmosphere or in degassed buffers.  DpgC functions in the presence of large 
concentrations of ethylenediaminetetraaectic acid (EDTA) and atomic absorption analysis 
failed to reveal any stoichiometric bound metals.  UV/visible absorbance measurements 
as well as mass spectrometry data indicated an absence of any cofactor such as flavin, 
pterin or iron.  Deuterium exchange assays showed that the α−C hydrogens of Dpa-CoA 
exchange with solvent 
when incubated with 
DpgC under anaerobic 
conditions (Figure 
13).  Crotonase 
enzymes process CoA-thioester substrates through enolate stabilization, this fact leads to 
the proposal that DpgC binds a Dpa-CoA enolate.  This electron rich intermediate would 
then react with O2 to generate the product.  These biochemical data raise the crucial 
question:  How does DpgC activate molecular oxygen for reaction with organic 
substrates?  A crystal structure of DpgC bond to a substrate mimic would answer how it 
performs this chemistry without a metal or cofactor.  Understanding the way organic 
Figure 13:  Deuterium exchange assay with DpgC and substrate 
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cofactors assist oxygenases is instructive as to how DpgC might function.  Biochemical 
work on other cofactor and metal independent oxygenases also provides some insight into 
how such a unique enzyme carries out this chemistry. 
 
II.  Activation of molecular oxygen in nature  
 
The role of cofactors in enzyme catalyzed oxidations 
 Chemical transformations involving molecular oxygen and organic substrates are 
complex processes.  Molecular oxygen is in the triplet state, making it inert toward direct 
reaction with the vast majority of organic molecules, which are in the singlet state.30 A 
reaction between two molecules in different spin states violates the conservation of 
angular momentum.  Enzymes use a variety of techniques to overcome this barrier.  
Metalloenzymes use tightly bound transition metals, typically iron or copper, to catalyze 
a variety of transformations.  Interesting examples of metalloenzyme chemistry in 
vancomycin biosynthesis are discussed in the appendix of this thesis.  Enzymes also use 
the organic cofactor flavin in a wide array of chemical reactions.  Applications of 
flavoenzymes range from histone modification to light emission.31 In its reduced form 
Figure 14:  Reduction of molecular oxygen to superoxide by reduced flavin, spin states of oxygen and a 
carbanion 
  15 
flavin represents an electron rich species capable of reducing molecular oxygen through 
single electron transfer (Figure 14).  Following the reduction of molecular oxygen to 
superoxide, a common intermediate is a peroxyanion.  This species has been identified in 
studies of flavin-dependent monooxygenases, enzymes that insert one atom of molecular 
oxygen while reducing the other oxygen atom to H2O. 
 Baeyer-Villiger monooxygenases use flavin, NADPH, and molecular oxygen to 
catalyze the insertion of an oxygen atom into a carbon-carbon bond (Figure 13).  This 
class of enzymes is of particular biotechnological interest due to the wide use of Baeyer-
Villiger reactions in 
synthetic organic 
chemistry.  Kinetic 
and spectroscopic 
studies have shown 
the enzymatic 
mechanism is 
conceptually 
identical to the nonenzymatic mechanism.32 The key feature of the enzymatic mechanism 
is the reaction of reduced flavin with molecular oxygen to produce a stable flavin-
peroxide intermediate.33 The Mattevi group solved the crystal structure of a Baeyer 
Villiger monooxygenase, phenyl acetone moonoxygenase (PAMO).34 PAMO showed the 
highest structural similarity to the flavoprotein class of disulfide oxidoreductases, which 
are comprised of two domains: a flavin binding domain, and an NADPH binding domain.  
PAMO makes van der Waals contacts through several aromatic amino acids (Trp55, 
Figure 15:  Catalytic cycle of the Baeyer-Villiger monooxygenase PAMO 
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Tyr60 and Tyr72) on the si face of the bound flavin.  On the re face of flavin, Arg337 
forms a π-stacking interaction with the cofactor.  Arg337 is crucial to the catalytic 
activity of PAMO, as evidenced by the Arg337Ala mutant that lacks activity.  It is 
believed that once flavin is reduced, Arg337 stabilizes the negatively charged 
deprotonated intermediate, and then stabilizes the peroxanion intermediate.  Arg337 may 
also be involved in the Criegee intermediate that leads to product formation.34 
 Glucose oxidase (GO) is a flavin dependent enzyme that catalyzes a hydride 
transfer from the anomeric C-H bond of glucose to FAD and the oxidation of FADH- by 
O2.  The rate-limiting step of this reaction is the single electron transfer from the 
negatively charged cofactor to molecular oxygen to from a caged radical pair.  A crystal 
structure of GO revealed a histidine residue situated above the C4a-N5 position of the 
flavin molecule.35 Kinetic studies of His516 mutant constructs showed this residue to be 
chiefly responsible for catalyzing the reaction between FADH- and O2.  In fact, a general 
Figure 16:  The active site of PAMO.  Arg337 over the C4A of flavin, ideally situated to deprotonate 
the substrate and stabilize the flavinperoxy intermediate.  The opposite face of the flavin makes van der 
Waals contacts with aromatic residues.  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feature of flavoprotein oxidases is a correlation between the rate of O2 activation by 
FADH- and a positively charged residue in the active site.   
 The critical role arginine and 
histidine residues play in deprotonation 
and stabilization of flavin cofactors is 
instructive to the way in which cofactor-
independent oxygenases carry out anion 
stabilization.  The path of negative charge 
accumulation followed by single electron 
transfer to molecular oxygen is thought to 
be shared by flavoenzymes and cofactor-
independent oxygenases. 
  
Cofactor and metal independent oxygenases 
 Oxygenases directly incorporate either one or two atoms of oxygen from 
molecular oxygen into their substrates.  These enzymes are involved in biological 
processes ranging from degradation of natural and xenobiotic compounds to secondary 
metabolite tailoring.36 Because the chemistry of these enzymes is regioselective and 
stereospecific, they are attractive targets for adaptation to a wide range of reactions.  The 
vast majority of characterized oxygenases use transition metals or organic cofactors to 
activate triplet molecular oxygen for diverse oxidation chemistry.  However, there is a 
small class of enzymes that perform oxidation chemistry without the use of a metal or 
Figure 17:  The active site of glucose oxidase.  
The location of the water molecule, red sphere is 
believed to mimic the peroxy intermediate  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cofactor.  The study of these enzymes leads to the question of how molecular oxygen is 
activated without prosthetic groups such as iron, copper or flavin cofactors. 
 
Cofactor-independent monooxygenases in polyketide biosynthesis  
The synthesis of polyketide natural products draws several analogies to NRPS 
biosynthesis because of the assembly-line nature of the polyketide synthase (PKS) 
systems.37 For this reason there 
has been a great deal of work 
surrounding the manipulation of 
such systems towards 
combinatorial biosynthesis.  
Tailoring steps in polyketide 
biosynthesis are the subject of 
engineering efforts due to the potential for analog development.  Cofactor-independent 
oxygenases identified from polyketide tailoring steps provide insight towards enzymatic 
oxygen activation.  In 1993, Shen and Hutchinson isolated tetracenomycin F1 
monooxygenase (TcmH) from Streptomyces glaucescens.38 This small, 12.6 kDa enzyme 
catalyzes the oxidation of naphthacenone tetracenomycin F1 at position C-5 to form 5,12-
napthacenequinone tetracenomycin D3 (Figure 18).  It was determined that TcmH simply 
requires molecular oxygen and the substrate to carry out this reaction.  One atom of 
molecular oxygen is incorporated into the product while the other is reduced to water.  
Based on initial biochemical characterization of the enzyme, it was thought that a 
histidine residue was involved in deprotonation of the substrate and stabilization of an 
Figure 18:  Chemistry of the cofactor-independent 
monooxygenases (A) TcmH and (B) ActVa-orf6    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anionic intermediate.  Greater detail on the mechanism of this monooxygenase was 
provided by the structure of a homolog, ActVA-Orf6, from Streptomyces coelicolor.39 
 The monooxygenase ActVA-Orf6 catalyzes the oxidation of 6-
deoxydihydrokalafungin (6-DDHK) to dihydrokalafungin (DHK), and is 39% identical to 
TcmH.  ActVA-Orf6 also catalyzes the same oxidation as TcmH on tetracenomycin F1 
(Figure 18).  As with TcmH, a histidine residue was assumed to play a major role in the 
catalysis of ActVA-Orf6.  The mutation of a conserved histidine to a His52Gln construct 
showed total loss of activity in ActVA-Orf6.  This initial biochemical data furthered the 
theory of a histidine residue playing the role of substrate deprotonation and anion 
stabilization.   
The X-ray crystal structures of ActVA-Orf6 were solved unbound as well as 
bound to four substrate and product analogs.   The overall fold of ActVA-Orf6 resembles 
the ferredoxin family of enzymes.  This enzyme is the first example of an oxygenase in 
the ferredoxin family, representing another functionality for this diverse group of 
enzymes.  The structure showed that the highly conserved His52 residue is not involved 
in catalysis; instead it makes contacts at the dimer interface.  The formation of a dimer in 
ActVA-Orf6 is especially important as a C-terminal β-strand contributes to the β-sheet of 
the other monomer, completing the active site.  Although structural analysis of His52 
ruled out a catalytic role similar to a flavin dependent enzyme, analysis of the active site 
bound to substrate and product analogs lead to a mechanistic proposal similar to flavin 
chemistry.   
 The active site of ActVA-Orf6 did not display any electron density consistent 
with an organic cofactor, metal or metal-binding site, supporting the claim of ActVA-
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Orf6 being a cofactor-independent monooxygenase.  Residues identified in the active site 
as being important for catalysis were Tyr51, Asn62, Trp66 and Tyr72.  Trp66 and Tyr72 
form hydrogen bonds with the hydroxyl groups at C11 and C13, respectively.  These 
interactions are crucial to orienting the substrate in the active site, and for creating a 
buildup of negative charge on the substrate.  Asn62 and Tyr61 orient a water molecule 
that facilites deprotonation at the site of oxidation.  Sciara et al. propose that after 
substrate deprotonation, molecular oxygen is reduced by the substrate and then forms a 
peroxo intermediate stabilized by Asn62 (Figure 19).39 This work provides some insight 
into substrate binding of a cofactor-independent oxygenase.  However, the small 
molecules bound in the crystallographic studies differ from the substrate and may not 
give an accurate picture of the active site geometry upon substrate binding.  The relaxed 
specificity of this class of cofactor-independent monooxygenases is evident in the 
Figure 19:  Proposed mechanism of ActVA-orf6  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structural data of the active site.  Very little concerning oxygen binding was gained from 
this work.  With regard to how these enzymes bind and activate molecular oxygen very 
little was known at this point.  An interesting aspect of this work is the identification of a 
ferredoxin fold for these enzymes, which was unexpected since sequence identity is low, 
less than 15% over fewer than 90 structurally equivalent amino acids.  It had originally 
been proposed that TcmH and ActVA-Orf6 could represent a novel protein fold.  The 
identification of these enzymes in the ferredoxin family shows the power of divergent 
evolution to develop broad functionality in an enzyme family.  
Further examples of cofactor-independent oxygenases also come from polyketide 
biosynthesis, and are members of a different protein fold.  Beinker et al. solved the 
structures of SnoaL2 and AclR, hydroxylases found in the nogalamycin and aklavinone 
biosynthetic pathways, respectively.40 These hydroxylases of about 140 amino acids in 
size show no sequence similarity to flavin or metal-dependent hydroxylases.  However, 
they do show approximately 25% sequence identity to polyketide cyclases.  The closest 
homologues to SnoaL2 and AclR are the polyketide cyclases SnoaL and AknH found in 
the corresponding biosynthetic pathways.  In the case of actinorhodin biosynthesis, a 
polyketide cyclase and cofactor-independent oxygenase was present both having the 
same protein fold.  A strikingly similar case evolved in the nogalamycin and aklavinone 
biosynthetic pathways.  A single protein scaffold gave rise to a cyclase and cofactor-
independent oxygenase.  Each case represents a different protein fold that has given rise 
to this functionality. 
This evolution of function shows that a variety of protein scaffolds can bind and 
activate a substrate for cofactor-independent oxygenation.   When such a scaffold is 
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present in a biosynthetic pathway, oxygenase function can evolve when required by a 
particular organism.  It is unclear if the presence of cyclase and oxygenase from the same 
fold in a particular biosynthetic pathway has any significance.  Do these two chemical 
functionalities have a correlation that makes them closely related from an evolutionary 
perspective? 
 
Cofactor-independent dioxygenases in heteroaromatic degradation pathways 
 1H-3-Hydroxy-4-oxoquinaldine 2,4-dioxygenase (Hod) from Arthrobacter ilicis 
and 1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase (Qdo) from Pseudomonas putida are 
part of the anthranilate pathway of quinaldine and 4-quinoline degradation, 
respectively.36    These enzymes open 
hetercyclic ring systems through the 
insertion of dioxygen at the C2 and C4 
position, which leads to the cleavage of two 
carbon-carbon bonds and the release of 
carbon monoxide (Figure 20).  Biochemical 
and spectroscopic characterization of Hod and Qdo have shown that neither contains a 
metal or organic cofactor.41 Sequence analysis of these ring-cleaving dioxygenases shows 
no similarity to known oxygenases.  Hod and Qdo are members of the α/β hydrolase 
superfamily of proteins.  Along with luciferase, they are the only oxygenases in this 
catalytically diverse group of enzymes.  The α/β hydrolase family contains a highly 
conserved catalytic triad found at a “nucleophilic elbow.”  This triad contains a 
nucleophile (Ser, Asp or Cys) an acidic residue (Asp or Glu) and an absolutely conserved 
Figure 20:  Chemistry of the cofactor-
independent dioxygenase Hod  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histidine residue.  Hod and Qdo both have a histidine that aligns with the triad histidine 
of the α/β hydrolases and a serine as a potential nucleophile.  These residues are found 
within a motif corresponding to the “nucleophilic elbow.”  The conserved histidine 
residue, His244 of Qdo, was found to be essential for catalysis, while the proposed 
conserved serine residue was not.  An acidic residue that would complete the catalytic 
triad was never identified.  This finding, in addition to the active serine mutant, suggests 
that Qdo and Hod do not contain the “canonical” α/β hydrolase catalytic triad. 
 The Fetzner lab performed steady-state kinetic analysis of Hod to better 
understand the function of cofactor-independent dioxygenases.42 They propose that 
His251, found in the conserved “nucleophilic elbow” position of α/β hydrolases, acts as a 
general base which deprotonates the substrate and stabilizes a dianion intermediate.  
Through electron paramagnetic resonance (EPR) studies, single electron oxidation of this 
high-energy intermediate was observed, which suggest the reduction of molecular oxygen 
to superoxide.  This kinetic data also demonstrated that Hod binds the organic substrate 
first then molecular oxygen.  Sequential substrate binding can be explained by a 
Figure 21:  Mechanism of Hod as proposed by the Fetzner group  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conformational change taking place upon binding of the first substrate, which allows for 
binding of the second substrate.  Conformation changes in flavin-dependent enzymes are 
thought to be required for reaction of reduced flavin with dioxygen.  With the crucial role 
of a conserved histidine identified by this kinetic work, comparisons to flavin enzymes 
are appropriate.  Based on this work, the Fetzner lab proposed a mechanism with a caged 
radical pair, even though caged radical pairs are undetectable by conventional EPR 
(Figure 19).  In addition to activating the organic substrate and binding molecular 
oxygen, the function of Hod is also thought to provide an environment suitable for 
electron transfer.  Structural characterization of a cofactor-independent dioxygenase 
would shed light on the nature of such an environment. 
 
Crystallographic studies of the cofactor-independent dioxygenase DpgC 
 Questions of substrate recognition, binding of molecular oxygen and activation of 
molecular oxygen in cofactor-independent oxygenases remain largely unanswered.  It is 
generally assumed the substrate plays a role in oxygen activation, yet how this is 
achieved was largely a mystery until recently.  Our work on the crystal structure of DpgC 
bound to an isosteric substrate mimic reveals a great deal about oxygen binding and 
substrate activation.  The active site environment binds molecular oxygen and is also 
suitable for single electron transfer.  Our efforts represent the first crystallographic 
structure of a cofactor-independent dioxygenase.  Not only does the study of this enzyme 
provide information on oxygen activation, it also teaches us about the synthesis of a 
crucial amino acid monomer in the powerful antibiotic vancomycin.  The amino acid Dpg 
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is incorporated into a position in vancomycin amenable to substitution, which makes 
detailed knowledge of Dpg biosynthesis useful in the production of vancomycin analogs. 
 
Chapter summaries: 
Chapter 1:  Introduction:  Non-ribosomal peptides and the biosynthesis of non-
proteinogenic amino acids through unique oxidation chemistry. 
 
Chapter 2:  Solving the apo-structure of DpgC:  A cofactor independent 
dioxygenase in the vancomycin biosynthetic pathway.  Crystallography behind solving 
the structure of DpgC and the chemistry learned from the apo-structure. 
 
Chapter 3:  Structural basis for cofactor-independent dioxygenation in vancomycin 
biosynthesis:  Crystal structure of DpgC bound to an isosteric substrate mimic.  
Substrate recognition and catalysis identification based on the model of substrate mimic 
bound to DpgC. 
 
Chapter 4:  Probing the oxygen-binding pocket of DpgC.  Biochemical and 
crystallographic studies of the DpgC oxygen-binding pocket.  Proposal of two possible 
paths for molecular oxygen from the initial oxygen-binding pocket in the DpgC active 
site. 
 
Chapter 5:  Biochemical characterization and efforts toward structural 
characterization of a non-ribosomal peptide synthetase module from Thermobifida 
  26 
fusca.  Discussion of the fuscachelin pathway, an NRPS pathway that produces a natural 
product recently elucidated in the Bruner lab.  The NRPS module FscI was biochemically 
characterized for adenylation domain specificity and an effort towards structurally 
characterizing the multi-domain module was undertook through X-ray crystallography. 
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Introduction  
It was established early in the study of DpgC that, based on the primary structure, 
the enzyme is homologous to the crotonase superfamily.1 An enzyme superfamily is 
defined by a common structural strategy used to lower the free energies of chemically 
similar intermediates.2 The crotonase superfamily is characterized by stabilization of 
coenzyme A acyl enolate 
intermediates (Figure 1).  From 
these common intermediates, 
members of the superfamily 
catalyze a wide range of 
reactions, thought to emerge 
through divergent evolution.3 In 
the case of enzymes, divergence 
is achieved by maintaining the 
functional groups that form the 
common intermediate, while adding and subtracting groups leading to various products.4 
The structural motif common to crotonase domains is an “oxyanion hole” formed by two 
backbone amide NH groups, which stabilizes the enolate anion form of acyl-CoA 
substrates. 
 Crotonase enzymes catalyze a diverse array of reactions, including 
dehalogenation, hydration and dehydration, decarboxylation, formation and cleavage of 
carbon-carbon bonds and hydrolysis of thioesters (Figure 2).    Several structures of 
Figure 1:  Initial catalytic step of the crotonase superfamily 
of enzymes 
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crotonase enzymes have been solved, which gives structural basis for the chemistry of 
this superfamily.2 
 Enoyl-CoA hydratase, referred to as crotonase from which the superfamily gets its 
name, catalyzes addition of water to α,β-unsaturated enoyl-CoA thioesters.5  Crotonase is 
involved in the β-oxidation cycle of long chain fatty-
acids.  The Wierenga lab solved the crystal structure 
of crotonase bound to a substrate analog providing 
insight into how the enzyme performs its chemistry.6,7   
Glu144 of crotonase activates a water 
molecule that adds into the β-carbon of the substrate 
(Figure 3A).  This use of a CoA enolate intermediate 
in the example of crotonase is more typical of the 
crotonase superfamily than 4-chlorobenzoyl CoA 
dehalogenase (Figure 3B).   
4-chlorobenzoyl-CoA dehalogenase catalyzes the dechlorination and subsequent 
hydration of 4-chlorobenzoyl-CoA.8,9 The Holden group solved the structure of this 
member of the crotonase superfamily bound to its product in order to elucidate the role of 
the oxyanion hole and enolate intermediate in this transformation.10 The backbone amides 
of Phe64 and Gly114 form the oxyanion hole that holds the carbonyl of the thioester.  
Phe64, Trp89 and Trp137 form an aromatic and hydrophobic pocket around the 4-
chlorobenzoyl moiety of the substrate.  The oxyanion hole activates the C4 position for 
formation of the Meisenheimer complex with Asp145 (Figure 3B).  This use of the 
oxyanion hole is quite different from hydratase enzymes of the crotonase superfamily. 
Figure 2:  Reactions catalyzed by 
crotonase superfamily:  A.  
hydratase B. dehalogenase C. 
isomerase D.decarboxylase 
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 DpgC represents the first known example of oxidation/reduction chemistry from 
the crotonase superfamily.11 Similar to ActVA-Orf6 and SnoaL2 discussed in the first 
chapter of this thesis, DpgC demonstrates new reactivity from a diverse protein 
scaffold.12,13 A crystal structure of DpgC would shed light on how the stabilization of an 
enolate intermediate activates the substrate for a four-electron oxidation and thioester 
cleavage.  A crystal structure could also elucidate oxygen binding and activation.   
Unfortunately the structure of DpgC unbound to an inhibitor or substrate mimic 
did not provide a complete picture of the active site chemistry.  There were several 
disordered regions in the crystal structure where the electron density could not be 
interpreted.  The 
apo-structure did 
provide some 
information 
concerning the 
overall fold of the 
enzyme and the 
interface between 
the monomers.  The 
N-terminal ~third of the enzyme, which showed no sequence homology to any deposited 
protein sequences, was elucidated in this structure and was determined to be a novel fold.   
 
 
 
Figure 3: Proposed mechanisms for hydratase and dehalogenase 
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Overexpression and purfication of DpgC 
 DpgC from the A47934 gene cluster was cloned from cosmid DNA (provided by 
G.D. Wright, McMaster University) into the pET30a vector.  Upon transformation into 
Escherichia coli and induction of overexpression, 
a significant amount of DpgC was produced, 10 
mg/L of growth media.  DpgC was cloned with a 
hexa-histidine tag attached to the N-terminus of 
the protein.  This allowed for purification with 
Ni-NTA affinity resin.  After elution from the 
resin, the hexa-histidine tag was cleaved from 
DpgC with the protease enterokinase.  Successful crystallization requires protein to be 
purified to high homogeneity.  To obtain DpgC suitable for crystallography, the enzyme 
was furthered purified using a two-step protocol: anion-exchange column followed by 
size exclusion chromatography.  This provided DpgC in high enough purity for high-
throughput crystallography screens. 
 
Crystallization and initial X-Ray data collection of DpgC 
 Work on crystallizing DpgC began with screening several DpgC homologues 
from various vancomycin family biosynthetic pathways against high-throughput crystal 
screens.  Due to the high sequence homology, approximately 70% identity and 80% 
similarity, crystallization of any DpgC homolog should provide a model applicable to the 
entire family of enzymes.  After the purification procedure described above, DpgC from 
A47934 was found to crystallize in 95 mM NaHEPES, 0.94 M NaCl and 1.3 M 
                  
Figure 4:  The vancomycin family 
member A47934 
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(NH4)2SO4, pH 7.5.  Data was collected on these crystals at our home source, a rotating 
copper anode X-ray generator.  Analysis of diffraction data showed DpgC crystallizes in 
the R3 space group with unit cell dimensions of a,b=138.7 Å, c=239.7 Å, α=β=90o, 
γ=120o.  Based on the Matthews coefficient, we predicted each asymmetric unit would 
contain four DpgC monomers. 
 
Determining phase information 
 X-ray diffraction data of a macromolecule cannot be used to generate an electron 
density map in the absence of calculated phase information.  The reflections seen in an X-
ray diffraction pattern are the result of a wave of X-ray radiation diffracting by 
interaction with clouds of electrons in a protein crystal then measured with a detector.  
Each reflection, or spot, on a diffraction pattern is made up of contributions from all 
scattering elements in a crystal.14 Like any wave, X-rays diffracted by a protein crystal 
can be described by three parameters: wavelength, amplitude and phase.  Amplitude of 
the X-ray is the square root of the reflection intensity measured from the diffraction 
pattern.  The wavelength of the X-rays diffracted by a crystal is constant with the 
diffraction source.  Phase information, however, cannot be obtained through direct 
analysis of diffraction data; this must be calculated through indirect methods.  With data 
describing amplitude, wavelength and phase, the wave function that represents the 
electron density can be solved through a Fourier transform.  To obtain the missing piece 
of data and solve the “phase problem,” three experimental methods are commonly used. 
When a highly homologous model of the protein of interest is available a method 
called molecular replacement can be employed.  In this case the homologous model is 
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used as a search model for the unknown phase information.  The phases from the 
structure factors of the search model are used to make initial estimations for the phases of 
the new protein.   
A second method involves soaking the protein of interest with a heavy atom salt 
then crystallizing the protein, or soaking an already formed crystal of the protein of 
interest with a heavy atom salt.  In this procedure, several heavy atom salts are screened 
in hopes of finding one that will bind consistently to the protein in several locations.  The 
diffraction data from this heavy atom derivative of the protein has structure factors from 
the heavy atom (FH) as well as the structure factors from the protein (FP;  FHP = FH + FP).  
Subtracting the data of a native crystal from the data of a heavy atom derivative crystal 
leaves structure factors only from the bound heavy atoms (FH = FHP – FP).  Computational 
methods can be used to determine the location of the bound heavy atoms, creating phase 
information that can then be applied to the rest of the protein.  This approach has the 
disadvantage of requiring data sets from separate crystals.  Because of the imperfections 
in a macromolecular crystal, data from two crystals of the same protein are not strictly 
identical, creating a larger error factor when comparing the two data sets.  
The third method of phase determination is anomalous dispersion, which relies on 
an atom in the protein having an anomalous diffraction edge.  In this case data collection 
is performed at certain wavelengths that create an anomalous signal upon X-ray 
diffraction by the atom. Anomalous data is generated because certain atoms absorb X-
rays of certain wavelengths anomalously causing inequality in symmetry related 
reflections.  Data is collected as either single-wavelength anomalous dispersion (SAD), 
or multi-wavelength anomalous dispersion (MAD).  In the case of MAD, multiple data 
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sets are collected on a single crystal at different wavelengths.  These sets are then 
compared to generate phase information.  SAD collects a single data set at the absorption 
edge of the heavy atom incorporated into the protein.  This provides adequate data to 
determine phase information.  SAD has recently become the common method for 
anomalous data collection.  Powerful software has made the collection of multiple data 
sets increasingly unnecessary.15 Analysis of the anomalous data allows for the atoms to 
be located, and phase information to be calculated.  Selenium atoms have an absorption 
edge within the range of synchrotron radiation.  This was the first heavy atom 
incorporated into DpgC. 
 
DpgC heavy atom soaks:  MIR and anomalous data collection 
 DpgC crystals were soaked with a range of heavy atom salts, including HgCl2, 
HgOAc, NH4PtCl4, KPtCl6.  Several datasets were collected on the heavy atom soaked 
crystals on our home source.  Patterson maps of the derivative crystals were made in an 
attempt to derive phase information.  Peaks observed in Patterson maps represent vectors 
between atoms.  The observed Patterson map shown is based on a subtraction of a native 
data set from a HgCl2 derivative DpgC crystal (Figure 5).  This subtraction should result 
in peaks representing vectors only between heavy atoms in the crystal.  A calculated 
Patterson map is shown along with an overlay of the two maps.  The possible correlation 
between the calculated and observed map gave some hope that the crystal had bound Hg 
atoms in an ordered and consistent fashion.  Attempts to use this data to determine phase 
information through the MIR strategy and calculate an electron density map were 
unsuccessful.  In order to determine whether DpgC had bound any heavy atoms, crystals 
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were sent to the National Synchrotron Light Source (NSLS) to collect anomalous data. 
Scans of the crystals showed very weak anomalous signal (Figure 8).  Data sets were 
collected at the absorption edge for the specific heavy atom.  None of the derivative 
crystals gave a strong enough anomalous signal to provide phase information.  At this 
point it became necessary to pursue an alternate strategy towards phase determination.   
 
 
 
 
 
Figure 5:  Upper left, experimentally determined Patterson map:  FHP-FP=HH.  Upper right, calculated 
Patterson map.  Overlay of experimental and calculated, lower middle 
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Initial SAD phasing experiments of DpgC 
 Once crystallization conditions for DpgC were optimized for diffraction quality, 
the enzyme was prepared in minimal media incorporating seleno-methionine (SeMet) 
into the peptide chain.  The strategy of a SeMet protein prep is to deprive the producing 
organism of methionine while supplying an excess of SeMet.  The media for a SeMet 
preparation is composed of necessary salts, including ammonium salts for nitrogen 
source, glucose as a carbon source and necessary amino acids.  Cysteine and other amino 
acids in the biosynthetic pathway towards methionine are excluded to keep methionine 
production as low as possible.  This SeMet prep produced a comparable amount of DpgC 
to the native prep.  Crystallization of the SeMet-substituted 
enzyme was successful using the native conditions.  
However, the SeMet derivative enzyme crystallized in a 
different space group from the native, P32, and the data 
could not be merged.  Crystal statistics produced from data 
reduction indicated possible twinning.  Crystal twinning is a phenomenon in which the 
entire asymmetric unit of a crystal adopts multiple conformations within the crystal 
lattice.  This results in each reflection in the diffraction pattern coming from two separate 
asymmetric units.  In some cases this data can be deconvoluted, however we were 
unsuccessful in any attempt to interpret the SeMet-DpgC data.  A possible explanation 
for the crystal twinning is the high number of methionines, ten, in DpgC.  Because 
selenium is easily oxidized, it is possible that a significant number of SeMet in DpgC 
became oxidized (Figure 6) and disrupted the formation of a properly ordered crystal. 
Once again, another strategy for phase determination was employed. 
 
 
Figure 6:  Oxidized SeMet 
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Figure 7:  Alignment of DpgC from five different glycopeptides antibiotic clusters.  DpgC from the 
A47934 pathway is listed first.  Teal highlights methionines not mutated in the triple mutant.  Green 
highlights methionines mutated to leucine  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SAD data collection on a triple mutant of DpgC, and phase determination 
 We believed DpgC produced twinned SeMet-derivative crystals due to the high 
(ten) number of methionines in the enzyme; therefore three methionines were mutated to 
leucine.  This strategy seems counterintuitive as removing methionines from a protein 
means reducing the anomalous signal from a SeMet derivative, therefore reducing the 
phasing power of the crystallographic data.  However, if such a mutant could lead to 
crystals that were not twinned, the remaining methionines should provide adequate 
phasing power to solve the structure.   
 A sequence alignment of DpgC homologues showed three of the methionines in 
A47934 DpgC were not conserved (Figure 7).  In all three of those positions, leucines 
were present in at least two DpgC homologues.  The three green-highlighted methionine 
Figure 8:  Anomalous energy scans.  SeMet DpgC triple mutant on right, HgCl2 derivative DpgC on left 
Fluorescence radiation (relative scale on Y-axis) is measured as X-ray wavelength (in eV on x-axis) is 
adjusted.  The sharp increase in from the SeMet DpgC radiation indicates an anomalous signal powerful 
enough for phasing.  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residues were mutated to leucine using the Stratagene QuikChange mutagenesis kit, 
M180L, M252L and M409L (Figure 7).  The triple mutant crystallized in the R3 space 
group and was not twinned according to analysis of data from our home source X-ray 
generator.  Anomalous data were then collected on the X4A beamline at NSLS.  Phasing 
calculations were carried out using the PHENIX16 software package, and 19 of a possible 
28 selenium atoms were located, with an overall figure of merit of 0.26.  Initial electron 
density maps were calculated using the SAD phases from PHENIX to 2.75 Å.  With 
electron density maps derived from the SAD phases, it was possible to begin building a 
model of DpgC. 
 
Building the structure of apo-DpgC 
 The model of DpgC was built using the program COOT17 with structure 
refinement by the CNS software package.18 DpgC contains four monomers in the 
asymmetric unit.  Each monomer forms a trimer through symmetry operations.  One of 
the four monomers displayed very poor electron density and could not be built beyond a 
largely incomplete polyserine model.  Two monomers had notable higher quality density 
and gave the most complete models.   
Unfortunately, even this monomer could not be completed due to several 
disordered regions (Figure 10).  Refinement statistics for the apo-DpgC model did not 
reach a level worthy of publication.  Although some structural knowledge of the enzyme 
was gained from this model, little could be deciphered about the chemistry of the 
enzyme.   
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 The biological unit of most crotonase enzymes is a dimer of trimers (Figure 9).2 
DpgC crystallized as four monomers, each monomer forms a trimer through symmetry 
operations.  Therefore, the biological unit of DpgC could be observed in this initial 
structure.  Hydrophobic α-helices make contacts between neighboring monomers.  A 
fascinating aspect of the structure is the structural characterization of the N-terminal 
~third of the enzyme.  The amino acid sequence of this portion is not homologous to any 
Figure 9:  DpgC looking down a three-fold axis of symmetry.  The biological unit of crotonase domains 
is a dimer of trimers 
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other known sequence, likewise the structure of this sequence shows no homology when 
put through a DALI structure homology search.  The C-terminal two-thirds of the 
Figure 10:  A. Amino acid sequence of DpgC with cartoon representations of α−helices and β−sheets 
above the sequence.  Highlighted in blue are residues that could not be built.  Asterisks indicate 
catalytically relevant residues.  B.  Two perspectives of DpgC monomer. 
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structure is largely homologous to crotonase domains in terms of its tertiary and 
quaternary structure.  In spite of this, elucidating the chemistry of the enzyme remains a 
mystery due to the poor electron density surrounding the active site. 
Crystallography depends on a protein existing in the same conformation in every 
asymmetric unit in the crystal.  The electron density in an area of disorder is either non-
existant or random.  As opposed to twinned data, which is the result of entire asymmetric 
units in different conformations, the data of apo-DpgC had all symmetric units properly 
aligned.  The areas surrounding the DpgC active site, as well as other portions on the 
enzyme, adopt multiple conformations in the crystal. If a protein is in multiple 
conformations within a crystal, X-ray diffraction will not lead to a clear image of the 
protein.  Previous studies of oxygenase enzymes indicate the substrate binds the active 
site followed by molecular oxygen.19,20  If a substrate mimic or inhibitor were bound to 
Figure 11:  Apo-DpgC showing an incomplete active site on the left.  Gly296 represents one of the two 
residues composing the oxyanion hole.  The complete structure from DpgC bound to substrate mimic, 
on the right.  The complete oxyanion hole is built, Ile235 and Gly296.  Not shown: the substrate mimic  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the protein, a more stable complex might form.  This stable complex might provide a 
structural basis for substrate and molecular oxygen binding to the protein. 
 DpgC unbound to a substrate mimic does not even provide a picture of the 
oxyanion hole in the active site (Figure 11).  When compared to the crystal structure 
bound to the substrate mimic, which will be discussed in the next chapter, it is clear that 
only one of the amides in the oxyanion hole is ordered.  This leaves us with little 
information on one of the fundamental aspects of crotonase enzymes, as well as a crucial 
aspect of the chemistry of DpgC.   
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Materials and Methods 
 
DpgC cloning and overexpression 
 DpgC from the A47934 gene cluster was cloned from cosmid DNA (provided by 
G.D. Wright, McMaster University) into the NcoI and HindIII sites of the pET30A 
vector.  The vector was transformed into BL21(DE3) cells and grown in LB media at 
37oC until cell density reached O.D.=0.5-0.7.  Overexpression was induced by adding 
100 µL 0.5 M IPTG, followed by overnight incubation at 18oC.  Cells were pelleted by 
centrifugation at 3,500 rpm for 20 minutes and lysed by passage through a French Press 
cell disruption system at 1,000 psi.  The cell lysate was incubated with Ni-NTA affinity 
resin (Qiagen) for 1 hr.  The resin was washed four times with 10 mL 500 mM NaCl, 20 
mM TrisHCl, pH 7.5.  The enzyme was eluted from the resin by washing two times with 
10 mL 500 mM NaCl, 250 mM imidazole, 20 mM TrisHCl, pH 7.5.  The elutions were 
dialyzed against 1 L of 100 mM NaCl, 20 mM TrisHCl, 1 mM βME, pH 7.5, followed by 
cleavage of the hexa-histidine tag with the protease enterokinase (2 days, 4oC).  The 
enzyme was further purified with a HiTrap-Q (GE Biosciences) ion exchange column 
(buffer A:  20 mM Tris, 1 mM βME, pH 7.5, buffer B: 1 M NaCl, 20 mM TrisHCl, 1 mM 
βME, pH 7.5) flow rate 2 mL/min, gradient 0-80% buffer B over 60 mL.  The enzyme 
was purified to homogeneity with a HiLoad 16/60 SuperDex 200 gel filtration column 
(GE Biosciences), buffer 100 mM NaCl, 20 mM TrisHCl, 1 mM βME, pH 7.5.  Flow rate 
1mL/min over 150 min, DpgC elutes around 60 min. 
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Crystallization of DpgC 
 DpgC was crystallized by the hanging drop method at 20 oC.  DpgC (1.5 µL of 10 
mg/mL DpgC in 20 mM Tris, 100 mM NaCl, pH 7.5) was mixed with 1.5 µL reservoir 
solution (95 mM HEPES, 0.94 M NaCl, 1.3 M (NH4)2SO4, pH 7.5).  Crystals appeared 
after two days.  Crystals were transferred to a cryoprotectant solution, composed of 
crystallization solution supplemented with 20% glycerol, and soaked for 10 min. before 
being flash frozen in liquid nitrogen.   
 
DpgC seleno-methionine prep 
 To M9 media (6 g Na2HPO4, 3 g KH2PO4, 1 g NH4Cl, 0.5 g NaCl in 1 L dd H2O) 
was added, 30 mg kanamycin, 10 mL 20% glucose, 2 mL 1M MgSO4, 0.05 mL 2M 
CaCl2, 0.1M 0.5% weight/volume (w/v) thiamine; 40 mg of the following amino acids:  
arginine, phenylalanine, tyrosine, tryptophan, lysine, histidine, serine, glutamate, 
aspartate, threonine, leucine, isoleucine and valine.  This mixture is inoculated with 1 mL 
of fresh overnight DpgC culture in LB broth, and grown to O.D.=0.5-0.7.  At this point 
100 mg each of threonine, lysine, phenylalanine and 50mg leucine, isoleucine and valine, 
and 120 mg DL-SeMet were added to media.  The culture is shaken for 15 min during 
which it is cooled to 18oC.  100 µL of 0.5 M IPTG is added, and the culture is shaken for 
16 hr at 18 oC.   
 Purification of the SeMet prep follows the protocol described above with a few 
exceptions.  All buffers were degassed for 10min with argon.  All buffers were identical 
except for containing 10 mM DTT.  SeMet-DpgC crystallized under the same conditions 
as native DpgC. 
  52 
 
DpgC heavy atom soaks 
 DpgC crystals were soaked in 95 mM HEPES, 0.94 M NaCl, 1.3 M Li2SO4, pH 
7.5, several times to remove any (NH4)2SO4 as the ammonium ion would bind to the 
metal salts competing with DpgC.  Heavy atoms salts HgCl2, HgOAc2, KPtCl6, 
NH4PtCl4, KPtCN4, PbNO3 and KAu(CN)2 were screened at concentrations of 1-5mM in 
the above mentioned solution.  Crystals were soaked in the heavy atom solution from 0.5 
hr. to 16 hr.  Data on the heavy atom soaked crystals was collected on our home source as 
well as on X26C at the NSLS.  No data sets yielded phasing power or anomalous signal. 
 
Site-directed mutagenesis of DpgC 
 Point mutations of DpgC were constructed using the QuikChange Multi Site-
Directed Mutagenesis Kit (Stratgene).  PCR gene amplification was performed using 
components provided; QuikChange Reaction Buffer, QuikChange Multi enzyme blend 
and dNTP mix.  The following primers and their reverse compliments were used for the 
triple mutant (modified sequences underlined):  M180L, 5’-CGG CTG ACC CTG TGT 
CGC GAC GAC CGC-3’;  M252L, 5’-GAC TTC CTG CTG CGC CGG GAA CTC 
GGC-3’; M409L, 5’-CGC GCG TAC CTG GCG GAG TTC GCC CTC-3’.  The PCR 
program consisted of an initial hold of 95oC for 1 min followed by 30 cycles of 95oC for 
1min, 55oC for 1 min, and 65oC for 13.5 min.  The template DNA was digested with 10U 
of DpnI for 1 hour at 37oC before transformation into XL1-Gold Ultracompetent Cells.  
The mutagenesis products were confirmed by DNA sequencing (Genewiz, Inc.). 
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DpgC structure determination using single-wavelength anomalous dispersion 
 The SeMet-DpgC triple mutant crystallized under native DpgC crystallization 
conditions.  Anomalous data was collected on the X4A beamline at NSLS, with a 
wavelength at the Se edge (0.98088 Å).  Diffraction data were indexed, integrated and 
scaled using the HKL2000 program.  Heavy atom phasing was carried out with the 
PHENIX16 software package. 
 
Model construction based on the SAD derived electron density maps 
The model was built with the program COOT17 and refined with the software 
suite CNS.18 Initial structural refinement was performed with non-crystallographic 
symmetry (NCS) restraints, after several rounds the restraints were removed from 
calculations.  Sigma-weighted simulated annealing composite omit maps (CNS) were 
used to build the model.  Issues completing the model are discussed in the text of chapter 
2. 
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Table 1:  Crystallography data collection and refinement statistics 
Data collection  SeMet DpgC   apo-DpgC 
Space group   R3    R3 
Cell dimensions 
 a, b, c (Å)  138.7, 138.7, 239.7  138.7, 138.7, 240.7 
 α, β, γ (o)  90, 90, 120   90, 90, 120 
Wavelength   0.98088   1.000001 
Resolution (Å)  2.75    2.21 
Rsym or Rmerge   0.061 (0.714)   0.085 (0.821) 
I/σI    13.94 (2.47)   26.37 (2.00) 
Completeness (%)  98.4 (99.1)   99.1 (95.5) 
Redundancy   3.6 (3.6)   3.0 (2.8) 
Refinement 
Resolution (Å)  2.75    2.21 
No. reflections  88780    86521  
Rwork/Rfree       0.319/0.330 
No. atoms       11099 
Average B-factor      59.5 
R.M.S.D. 
 Bond lengths (Å)     0.008 
 Bond angles (o)     1.5 
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Introduction 
 Aerobic organisms use molecular oxygen for critical processes such as energy 
production and synthesizing cellular components.  The standard reduction potential of the 
O2/H2O redox couple is +0.82V, making dioxygen a potentially strong oxidizing agent.1 
However, as discussed in chapter 1, molecular oxygen cannot directly react with the vast 
majority of organic substrates due to the conservation of angular momentum.  Nature has 
developed several methods to overcome this spin-forbidden reaction.  The vast majority 
of solutions found to the problem of inert triplet oxygen come from organic cofactors or 
enzyme bound transition metals.2   
Mechanistic studies of enzymatic molecular oxygen activation have focused on 
metalloenzymes.  In general, this body of work has shown metalloenzymes both perform 
electron transfer and electrostatic stabilization in a single step.3 Ligands bound to the 
metal center tune redox 
potentials of the systems 
towards increased 
reactivity with O2.4 The 
adjustable metal centers, 
single step electron transfer and charge stabilization are advantages that flavin-dependent 
enzymes do not have access to when activating oxygen.  Instead flavoenzymes use 
specialized protein environments to facilitate charge transfer.5 Flavin enzymology is 
frequently used as a guide to cofactor-independent oxygenation, as the substrate in 
cofactor-independent oxygenases is thought to function analogously to flavin cofactors.1   
Figure 1:  Single electron donation from reduced flavin to molecular 
oxygen 
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 Catalytic rates of O2 activation by flavin-dependent oxidases correlate to the 
presence of positively charged residues in the active site.  Roth et al. have shown the 
importance of a positively charged residue in the active site of the flavin-dependent 
enzyme glucose oxidase (GO).6 Through spectroscopic and kinetic analysis of this 
enzyme, the rate-limiting step was determined to be single electron transfer from the 
reduced flavin anion to molecular oxygen (Figure 1).  Kinetic analysis of GO activity 
over a pH range shows rate acceleration at low pH, supporting the importance of a 
positive charge in the active site. In the case of GO, a positively charged histidine in the 
active site was shown to dramatically increase the rate of reaction.  Roth et al. suggest a 
HisH+ in the active site may stabilize O2•- (superoxide), which would increase the overall 
reaction driving force.  The presence of charged amino acids are also implicated in 
creating the proper protein dielectric for electron transfer.  The kinetic data by Roth et al. 
show a simple process of oxygen diffusion to the bound flavin, followed by single 
electron transfer.  The importance of a charged residue in the active site led to the 
conclusion that enzymes using nonmetal cofactors for molecular oxygen activation are 
likely to use charged amino acids to facilitate electron transfer and stabilize 
intermediates.   
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Such studies of flavin-dependent enzymes provide clues on how the active site of 
DpgC might facilitate electron 
transfer and stabilize O2•-.  The 
DpgC active site has to 
provide an environment that 
will stabilize a negatively 
charged substrate and be 
suitable for electron transfer.  
The active site will also need a 
hydrophobic pocket to bind 
and orient molecular oxygen 
for reaction with the organic 
substrate. 
 Two mechanistic 
routes concerning cofactor-
independent dioxygenation 
have been suggested, in the 
case of Hod (1H-3-hydroxy-4-
oxoquinaldine 2,4-
dioxygenase).7  The first (Path A, Figure 2) involves hydrogen atom abstraction from the 
substrate to form a radical amino acid species, a histidinyl radical, in the active site.  The 
substrate radical then reacts with molecular oxygen, as they have become spin-paired 
species.  Next, single electron transfer occurs from the radical amino acid to the 
Figure 2:  Possible mechanisms of cofactor independent 
dioxygenation by Hod.  The use of a histidinyl radical is 
thought to be unlikely.  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hydroperoxyl radical species.  Hydrogen atom abstraction is typically observed in 
metalloenzymes, however this has not been described in the case of organic cofactors.  In 
fact, a histidinyl radical has been observed in bovine copper-zinc superoxide dimutase.8 
However, there are no known examples of catalytically competent histidinyl protein 
radicals.9 The more likely path of cofactor independent dioxygenation is single electron 
transfer from a deprotonated substrate to molecular oxygen (Path B, Figure 2).  The 
caged radical anion/superoxide pair would collapse to form a carbon-oxygen bond, 
followed by conversion to product, as shown.  This mechanism is similar to the suggested 
flavin activation.  
 The work of the Fetzner and Klinmann labs provides insight towards how 
enzymes facilitate single electron transfer from an electron rich organic intermediate.  We 
have addressed the issues of substrate activation, oxygen binding and active site 
environment leading to single electron transfer are addressed by solving the crystal 
structure of the cofactor-independent dioxygenase DpgC bound to an isosteric substrate 
mimic.  DpgC is the first example of a crystal structure from this class of enzymes.  
Through this work we have developed a clear picture of the starting complex between 
DpgC and its substrate. 
 
Rational design and synthesis of an isosteric substrate mimic for DpgC 
 DpgC catalyzes the four-electron oxidation of the α−C position of DpaCoA and 
cleaves the thioester bond to release coenzyme A and dihydroxyphenylglyoxylate 
(DpgX).10 To probe the powerful chemistry of DpgC, we designed a stable isosteric 
substrate mimic.  If cleavage of the thioester bond is prevented, the substrate will remain 
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bound in the 
active site and 
provide a picture 
of the substrate-
enzyme complex.  
It was not 
feasible to 
engineer the 
enzyme to 
prevent thioester 
cleavage; thus it 
became necessary 
to design a 
substrate analog 
that would be hydrolytically stable at this position.  An amide bond is isosteric to a 
thioester with the exception of a single hydrogen.  Compared to thioesters, amides are 
more resistant to hydrolysis.  Another advantage of replacing the thioester of the substrate 
with an amide is preventing deprotonation at the α−C position, by raising the pKa.  
Because amide α-protons have a higher pKa than thioester α-protons, it was reasoned 
that the amide analog might prevent deprotonation at this location.  Protonation at the C2 
position would provide a true substrate complex with the enzyme, suggesting a substrate 
mimic with a change of simply one atom, sulfur to nitrogen.  To synthesize such an 
inhibitor it is necessary to construct a coenzyme A analog with a terminal amine in place 
Figure 3:  Transformation performed by DpgC, substrate mimic of DpgC 
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of a thiol.  The biosynthesis of coenzyme A played a large role in our synthetic strategy 
for the substrate mimic, leading to a chemoenzymatic approach.11   
 The pantetheine portion of coenzyme A is biosynthesized from a sequential 
coupling of pantoate, β-alanine and cysteine.12   Pantetheine is then phosphorylated on 
the 
terminal alcohol, adenylated at that phosphate, and finally phosphorylated on the ribose 
ring.  Our synthesis works in a similar fashion.  In fact, three enzymes from CoA 
biosynthesis were cloned from E. coli genomic DNA and used for the final three steps of 
our synthesis.   
Ye Liu developed the protocol for amino-CoA synthesis.  The chemoenzymatic 
synthesis began with a solid-phase strategy to prepare the amino-pantetheine portion of 
Figure 4:  Biosynthesis of coenzyme A.  E1 = pantoate-b-alanine ligase, E2 = pantothenate kinase, E3 = 
phosphopantothenoyl cysteine synthetase, E4 = phosphopantothenoyl cysteine decarboxylase, E5 = 
phosphopantetheine adenylyl transferase (PPAT), E6 = dephospho coenzyme A kinase (DPCK)  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amino-CoA (Figure 5).11,13  First, trityl resin was loaded with diaminoethane.  FMOC-
protected β-alanine was then coupled to resin-bound diaminoethane.  After removal of 
the FMOC group, PMP-protected pantoic acid was coupled to the dipeptide.  
Simultaneous deprotection and release from the resin resulted in amino-pantetheine.  The 
synthesis is completed with the enzymes: pantetheine kinase (panK), phosphopantetheine 
Figure 5:  Chemoenzymatic synthesis of amino-coenzyme A 
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adenylyltransferase (PPAT) and dephosphocoenzyme A kinase (DPCK) in a one-pot 
reaction.  This synthesis is an efficient and practical route to amino-CoA analogs, which 
are powerful tools in mechanistic enzymology.  It is estimated that 4% of all enzymatic 
reactions use coenzyme A as a cofactor.  Amino-CoA can be used to make non-
hydrolyzable analogs for an enormous variety of enzyme-catalyzed reactions.  In the case 
of DpgC, coupling of amino-CoA to dihydroxyphenylacetic acid gives the substrate 
analog dihydroxyphenylacetyl-amino-CoA (Dpa-NH-CoA).   
  Ye Liu carried out inhibition studies of Dpa-NH-CoA with DpgC.  Inhibition 
assays were performed using the DTNB assay, which measures the presence of free thiols 
through formation of a spectroscopically active disulfide.14 The Ki of Dpa-NH-CoA was 
determined to be 2.7 ±0.3 µM, which is comparable to the Michaelis constant (KM) of the 
natural substrate.  Dpa-NH-CoA was recovered unchanged from DpgC assays.  Once 
Dpa-NH-CoA was established as a competitive inhibitor with reasonable kinetic 
parameters, crystallography experiments with DpgC and inhibitor were performed. 
 
Crystallization of DpgC with Dpa-NH-CoA 
 DpgC was overexpressed and purified as described in chapter 2.  Dpa-NH-CoA (2 
mM) was incubated with DpgC (12 mg/mL in 20 mM Tris, 100 mM NaCl at 20 oC for 2 
hr).  The enzyme/inhibitor mixture was screened against Hampton Research Crystal 
Screens I and II.  Inhibitor bound DpgC crystallized in 100 mM sodium citrate, 165 mM 
ammonium acetate and 24% (w/v) PEG 4000, pH 5.6, after two days.  The enzyme 
inhibitor complex crystallized in the space group P21212 with two trimers per asymmetric 
unit based on the Matthews coefficient.15   
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Structure solution of DpgC bound to Dpa-NH-CoA and model building 
 Phase information for the structure of DpgC bound to the substrate analog was 
calculated with the AMORE16 software package using the incomplete native structure, 
discussed in Chapter 2, as the search model.  AMORE found three monomers in the 
asymmetric unit that made up a trimer.  The biological unit of DpgC, a dimer of trimers, 
results from symmetry operations in the crystal.  Electron density corresponding to the 
protein is consistent and well defined throughout all three monomers.  The active site is 
well ordered and the substrate analog is clearly evident in the electron density maps.  
Unfortunately, the second trimer predicted by the Matthews coefficient could never be 
built.  An area in the asymmetric unit that would fit a second trimer contains electron 
density that does not resemble a protein structure.  It was suggested that this missing 
trimer was the result of lattice-translocation defect.17 This rare anomaly describes a 
protein that occupies several positions in the unit cell.  Density from such a region is not 
interpretable.  Although lattice translocation defect could explain the phenomenon the 
observed in our electron density maps, the effect cannot occur in crystals with P21212 
symmetry.  When the data was scaled in the lower symmetry space group P21, in which 
lattice translocation effect is possible, the incomplete electron density is still observed 
and still uncorrectable.  In an attempt to fill the empty portion of the unit cell, lower 
occupancy, overlapping trimers were placed using search programs such as AMORE.  
These experiments failed to place any trimers in the unit that improved refinement 
statistics.  After consulting with several experts in 
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the field of crystallography, proper identification and correction of the anomaly could not 
be reached.18,19,20  However, we are confident that the model of DpgC bound to the 
Figure 6:  A.  DpgC trimer looking down three-fold axis of symmetry.  B.  DpgC monomer, with 
substrate mimic colored red. 
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substrate mimic is a complete and accurate picture of the enzyme in a starting material 
complex.  All conclusions based on crystallographic evidence are corroborated with 
biochemical evidence.  Overall, the complex of DpgC with Dpa-NH-CoA provided an 
exciting look at how this unusual enzyme activates substrate and molecular oxygen for 
downstream chemistry. 
 
The active site of DpgC bound to Dpa-NH-CoA 
 As mentioned, the active of DpgC and the substrate mimic are well defined by the 
electron density maps.  The coenzyme A portion of the substrate mimic binds in the 
active site in an extended conformation with the adenosine moiety bent back around the 
molecule.  Lys238 and His222 make hydrogen bonding contacts with the  
phosphate group on the 4’ position of the ribose ring (Figure 7).  Tyr225 makes a 
hydrogen bonding contact with the β-phosphate of the substrate mimic.  The 
conformation of the adenosine group over the pantetheine portion of CoA is a typical 
binding motif in the crotonase 
superfamily.21 The N7 and 
exocyclic amine of the 
adenosine moiety make 
hydrogen bonds with the 
pantetheine group further 
stabilizing the observed 
conformation.  These aspects of 
substrate binding are important, 
Figure 7:  Dpa-NH-CoA bound to DpgC.  DpgC shown in 
surface, substrate mimic shown in stick and molecular oxygen 
in sphere representation. 
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as an N-acylcysteamine derivative of the substrate lacking the adenosine and most of the 
pantetheine portion is not turned over.22 However, these binding features do not reveal 
how DpgC achieves catalysis. 
 The 3,5-dihydroxyphenyl ring of the substrate mimic bound to DpgC gives a clear 
picture of how the substrate is activated for catalysis.  The 5-hydroxyl of Dpa-NH-CoA 
forms a water bridge with Glu255.  This is one interaction that creates a build-up of 
negative charge on the 
substrate.  The 3-
hydroxyl group makes a 
unique interaction with 
two residues:  Glu189 
forms a hydrogen bond 
with the 3-OH, while the 
face of the guanidinium 
group of Arg254 
stabilizes the emerging 
negative charge.  
Electron density maps 
clearly show the face of 
Arg254 closest to the 3-OH.  To our knowledge, this is the first observation of the ζ-
carbon of an arginine residue forming such an interaction.  With a negative charge being 
created on the 3-OH, one would expect the amine groups on Arg254 to quench the 
charge.  However the ζ-carbon of Arg254 is closest to the 3-OH, which positions an atom 
 
Figure 8:  Recognition of the 3,5-dihydroxyphnyl ring of the substrate 
by DpgC 
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with a partial positive charge near the hydroxyl group.  This is analogous to the function 
of histidine residues in flavin chemistry.6 The Arg254/Glu189 interaction is critical to 
catalytic turnover as demonstrated by biochemical work discussed later in this chapter.  
The described interaction of Arg254/Glu189 with the 3-OH demonstrates a build up of 
negative charge around the dihydroxyphenyl ring; however there is another crucial 
component of DpgC/substrate binding that prepares the substrate for catalysis.   
 The oxyanion hole discussed in the second chapter is clearly observed in the 
structure bound to the 
substrate mimic (Figure 
9).  The carbonyl of the 
substrate mimic is 
ideally oriented between 
the amide hydrogens of 
Gly296 and Ile235, 
which stabilizes the 
predicted thioester 
enolate intermediate in 
the reaction pathway.  
Formation of this 
enolate results from 
deprotonation at the α-C 
position of the substrate.  
The oxyanion hole functions to lower the pKa of this proton significantly.  A water 
Figure 9:  DpgC bound to the substrate mimic, Gly296 and Ile235 form 
the oxyanion hole 
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network anchored by Gln299 facilitates deprotonation at the α-C position.  Glutamine is 
conserved in all DpgC homologues at this location.  The use of a glutamate to anchor the 
water network would provide a stronger base for deprotonation, suggesting a role for 
Gln299 beyond deprotonation.  This possibility will be discussed chapter four.  Due to 
the location of the water network anchored by Gln299, deprotonation is predicted to 
occur at the proR hydrogen.  Thus oxygen will most likely attack the opposite face of the 
substrate.   
 At this position we observed unassigned electron density consistent in size and 
shape with molecular oxygen (Figure 10).  Each monomer of the trimer has density in the 
same location and similar orientation.  The orphan electron density is too large to be a 
water molecule.  The hydrophobic nature of the binding pocket makes the electron 
density unlikely to be 
a cationic metal.  The 
crystallization media 
contains no 
compounds that 
would fit in the 
binding pocket.  
Based on the 
chemistry of the 
enzyme and the 
environment of the 
potential oxygen-
Figure 10:  A composite omit electron density map showing the area 
around the substrate mimic, catalytically relevant waters and molecular 
oxygen. 
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binding pocket, it is reasonable to assign this electron density as molecular oxygen.   
Ordered molecular oxygen is rarely observed in protein crystal structures,23,24 especially 
when not in complex to a transition metal.25,26  
 Unequivocal assignment of the electron density as molecular oxygen is not 
possible based solely on the X-ray diffraction data.  Experiments regarding corroboration 
of the electron density as oxygen and probing the hydrophobic pocket through 
biochemical studies are discussed in the next chapter of this thesis.  Based on the 
evidence discussed in this chapter, a chemical mechanism for the dioxygenation reaction 
of DpgC was proposed (Figure 11).   
Figure 11:  Proposed mechanism for the cofactor-independent dioxygenase DpgC 
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 The first step of the proposed reaction is deprotonation at the α−C of the substrate 
and formation of a thioester enolate.  The backbone amides of Gly296 and Ile235 
stabilize this intermediate in the tradition of the crotonase superfamily.21 The thioester 
enolate combined with the Arg254 and Glu189 interactions with the 3-OH to create a 
highly conjugated, negatively charged intermediate.  Molecular oxygen is oriented in the 
active site to react with this intermediate.  Similar to flavin chemistry, we propose a 
reaction mechanism with molecular oxygen is a two-step process.  The first step is single 
electron transfer from the substrate to triplet oxygen.  This reduction forms a conjugated 
radical cation/superoxide pair.  The second step of molecular oxygen activation is 
reaction of the radical cation substrate intermediate with superoxide in a spin-allowed, 
bond-forming process to give the peroxide intermediate.   
Based on modeling intermediates in the active site, Gln299 may play a role in 
stabilizing the peroxy intermediate.  It has been suggested that a glutamine or asparagine 
residue performs stabilization of peroxy intermediates in flavin and cofactor independent 
oxygenases.  Such a role 
may explain the use of a 
glutamine in this 
position as opposed to a 
glutamate.  The 
peroxide intermediate can attack the thioester bond, still positioned in the oxyanion hole, 
which releases coenzyme A and forms a 1,2-dioxetanone intermediate.  DpgC must 
carefully direct break down of the resulting dioxetanone to produce the glyoxylate 
Figure 12:  The reaction catalyzed by firefly luciferase,which stabilizes 
a 1,2-dioxetanone intermediate, the final product is in an excited state 
and emits light 
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product and avoid decomposition to carbon dioxide.  The 1,2-dioxetanone species is 
observed in firefly luciferase (Figure 12).27  In this system the dioxetanone breaks down 
to CO2 and product.  There is also biochemical evidence for the organic radical and 
superoxide pair in the cofactor independent dioxygenase Hod.7  The suggested role of 
Arg254 in DpgC, which stabilizes a negative charge on the 3-OH, is analogous to the 
proposed role of a histidine residue in stabilizing reduced flavin cofactors.  The role of 
Arg254 as well as features of substrate recognition was further explored through 
crystallographic and biochemical characterization. 
 
Mutagenesis studies of substrate recognition and catalysis by DpgC 
 Elisha Fielding performed mutation studies of several active site residues.   These 
studies showed residues Arg254 and Glu189 to be most important to catalysis as the 
Arg254Lys and Glu189Gln constructs showed significant decreases in enzyme kinetics.  
These results emphasize the importance of this unique dyad in catalysis of the enzyme.  
Two mutant constructs of active site residues, Glu255Gln and Gln299Asn, showed 
comparable kinetic statistics to the wild type.22   
Kinetic parameters, KM and kcat, of alternate substrates were also determined in 
order to establish the catalytic significance of the hydroxyl groups on the phenyl ring of 
Table 1:  Kinetic parametes for DpgC mutant enzymes with the natural substrate Dpa-
CoA 
 
DpgC  KM (µM)  kcat (min-1)  kcat/KM 
wild type 3.9 ±0.6  10.32 ±0.42  1 
R254K  217 ±46  5.17 ±0.32  0.009 
E189Q  64 ±13   5.12 ±0.41  0.029 
E255Q  3.6 ±1.9  9.18 ±0.78  0.959 
Q299N 2.5 ±1.1  4.14 ±0.21  0.619 
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the substrate (Figure 13).  3-hydroxyphenylacetyl CoA has kinetic parameters 
comparable to the natural substrate.  The other two alternate substrates showed 
significantly decreased turnover and binding affinity. 
The data from the R254K and E189Q mutants along with the alternate substrates 
indicates the importance of a single hydroxyl group forming a phenoxide on the ring.  
The role of the atypical interaction between Arg254 and the 3-OH could be necessary to 
stabilize the negative charge on the 3-position phenoxide without presenting an acidic 
proton. 
 
Conclusion 
 The structure of DpgC bound to a substrate mimic has elucidated the chemistry of 
this unusual enzyme.  The identification of an oxygen binding hydrophobic pocket is a 
key discovery in the field of enzymatic oxygen activation.  The structure reveals novel 
Table 2:  Kinetic parameters of alternate Phenylacetyl-CoA substrates for DpgC 
 
Substrate   KM (µM)  kcat (min-1)  kcat/KM* 
  3.9 ±0.6  10.32 ±0.36  1 
 
  4.4 ±1.4  7.52 ±0.57  0.650 
 
   102 ±37  3.84 ±0.36  0.014 
 
  851 ±361  13.32 ±2.33  0.006 
OH
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O
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OH
O
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insights that can be applied to the general mechanism of oxygen activation.  Future work 
will involve crystallographically characterizing intermediates along the DpgC pathway. 
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Materials and methods 
 
Synthesis of dihydroxyphenylacetyl-amino-CoA (Dpa-NH-CoA)11  
Synthesis of amino-pantetheine.  PMP-protected pantoic 
acid was synthesized using the published procedure.13  
Panetheine analog was synthesized on solid support using trityl chloride polystyrene resin 
(Novabiochem, loading 1.6 mmol/g) in a solid phase synthesis vessel.  The resin (1.00g, 
1.6mmol) was swelled in DCM (8 mL) for 1 hr. before 1,2 diaminoethane (1.07mL, 16.0 
mmol) was added.  The suspension was agitated on a shaker for 16 hr., then drained and 
rinsed with NMP (N-methyl-2-pyrrolidinone) 5x20 mL to give 1,2-diaminoethane-
functionalized resin.  A solution of FMOC-β-alanine (1.49 g, 4.80 mmol) PyBOP (2.50g , 
4.80 mmol), and DIPEA (1.67 mL, 9.60 mmol) in NMP (4 mL) was added to the resin 
and the suspension was agitated for 2 hr., then drained and rinsed with NMP (5x20 mL).  
The FMOC protecting group was removed by treating the resin with 20% (v/v) 
piperidine/NMP (20 mL) for 20 min, which was then rinsed with NMP (5x 20 mL).  A 
solution of PMP-protected pantoic acid (1.28 g, 4.80 mmol), PyBOP (2.50 g, 4.80 mmol) 
and DIPEA (1.67 mL, 9.60 mmol) in NMP (4 mL) was added to the resin and the 
suspension was agitated for 4 hr.  After rinsing with NMP (5x 20 mL) and DCM (5x 20 
mL), the resin was treated with 15 mL of 5% (v/v) trifluoroacetic acid (TFA) and 2% 
(v/v) triethylsilane (TES) in DCM for 20 min to cleave the product from the resin.  The 
resin was washed with 5% TFA in DCM (10 mL).  The cleavage solution and wash 
solution were combined and concentrated in vacuo.  The residue was redissolved in 10 
N
H
N
H
OH
O O
NH2HO
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mL of 10% (v/v) TFA/H2O.  The aqueous solution was extracted twice with diethyl ether 
(10 mL), and then lyophilized to give amino-pantetheine as a yellow oil.  The product 
was further purified by preparative HPLC (9 mL/min flow rate; gradient: 0-5 min, 5% B; 
5-25 min, 5-98% B, where A=0.1% TFA/H2O and B=CH3CN).  Chromatographs were 
monitored at 220 nm and amino-pantetheine eluted at 11.2 min.  Removal of solvents via 
lyophilization gave amino-pantetheine as a colorless oil (combined purified yield 70%, 
290 mg).  1H NMR (D2O, 300 MHz) δ 3.94 (s, 1H), 3.49-3.43 (m, 5H), 3.35 (d, J = 11.1 
Hz, 1H), 3.10 (t, J = 5.9 Hz, 2H), 2.48 (t, J = 5.9 Hz, 2H), 2.48 (t, J = 6.5 Hz, 2H), 0.88 
(s, 3H), 0.85 (s, 3H).  13C NMR (D2O, 100 MHz) δ 175.1, 147.9, 75.9, 68.5, 39.4, 38.8, 
37.0, 35.6, 20.7, 19.4.  HRMS (ESI+) m/z Calcd for C11H24N3O4 262.1767, found 
262.1768. 
 
Enzymatic preparation of amino-
coenzyme A.  The genes encoding 
pantetheine kinase (PanK), 
phosphopantetheine adenylyltransferase (PPAT) and dephospho coenzyme A kinase 
(DPCK) were each amplified from E. coli genomic DNA using the primers shown 
below:28 
PanK:  
5’ 5’-GGGAATTCCATATGACCGCCAGAAACATGCTTATGAG 
3’ 5’-CGCGGATCCAAGCTTTTATTTGCGTAGTCTGACCTCTTCTACCG 
PPAT:  
5’ 5’-GTCTCTAGAGCTAGCATGCAAAAACGGGCGATTTATCC 
O
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3’ 5’-CGCGGATCCAAGCTTCTACGCTAACTTCGCC 
DPCK: 
5’ 5’-GGGAATTCCATATGAGGTATATAGTTGCCTTAACGGGAG 
3’ 5’-CGCGGATCCAAGCTTTTACGGTTTTTCCTGTGAGACAAACTGC 
The amplified genes were digested (NdeI and HindIII for PanK and DPCK, and NheI and 
HindIII for PPAT) and ligated into the pET28a vector (Novagen).  The vectors were 
individually transformed and proteins were overexpressed in E. coli BL21(DE3) cells 
(Novagen).  For each enzyme, cells were harvested by centrifugation at 3500 rpm for 20 
min.  The cell pellets were suspended in 40 mL lysis buffer (20 mM Tris, 500 mM NaCl, 
pH 7.5) and lysed by passage through a French Press cell at 1000 psi.  The lysate was 
centrifuged at 10,000 rpm for 20 min and the supernatant was incubated with 1 mL Ni-
NTA resin (Qiagen) for 1 hr.  The resin was washed with lysis buffer (4x 15 mL) and the 
enzyme was eluted with 2x 15 mL elution buffer (20 mM Tris, 500 mM NaCl, 250 mM 
imidazole, pH 7.5).  The elution fractions were dialyzed against 1 L of 50 mM HEPES, 
250 mM NaCl, 2 mM MgCl2, pH 8.0 for 2 hr at 4oC.   
Enzymatic synthesis reactions were carried out at 37oC in a single-pot reaction.  
39.3 mg of amino-pantetheine was added to 30 mL of buffer solution (20 mM KCl, 10 
mM MgCl2, and 50 mM Tris, pH 9.0).  Next, 10 mg of PanK along with 152 mg of ATP 
was added and the reaction was allowed to shake for 30 min. 10 mg of PPAT in addition 
to 152 mg of ATP was added and the reaction was allowed to shake for 30 min.  Finally, 
10 mg of DPCK with 152 mg of ATP was added and the reaction shook for 45 min.  To 
terminate the reaction, 50% w/v trichloroacetic acid (TCA) was added to give a final 
concentration of 10% w/v in the reaction mixture.  After incubation on ice for 10 min, the 
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mixture was centrifuged at 5,000 rpm for 10 min.  The supernatant was lyophilized, and 
the crude reaction mixture was purified by preparative reverse-phase C18 HPLC using 
the following gradient:  9 mL/min; 0-5 min, 0% B; 5-25 min, 0-5% B, where A=0.1% 
TFA/H2O and B=CH3CN; amino-CoA eluted at 25.5 min.  After lyophilizing the purified 
product yield was 50%.   
Amino-coenzyme A Analog.  1H NMR (D2O, 400 MHz) δ 8.69 (s, 1H), 8.45 (s, 1H), 
6.24 (d, J = 5.5 Hz, 1H), 4.89-4.87 (m, 2H), 4.62 (br s, 1H), 4.29-4.27 (m, 2H), 4.04 (2, 
1H), 3.84 (q, J = 5.0 Hz, 1H), 3.66 (q, J = 6.0 Hz, 2H), 2.51 (t, J = 6.5 Hz, 2H), 0.95 (s, 
3H), 0.89 (s, 3H).  13C NMR (D2O, 126 MHz) δ 175.4, 175.0, 150.1, 148.7, 144.9, 142.7, 
118.8, 87.7, 83.8, 74.7, 74.3, 74.2, 71.9, 65.3, 39.4, 38.6, 37.0, 35.8, 35.6, 20.8, 19.1.  31P 
NMR (D2O, 121 MHz) δ 0.81, -9.87, -10.30.  HRMS (ESI+) m/z Calcd for 
C21H38N8O16P3 751.1619, found 751.1653. 
 
Synthesis of Dpa-NH-CoA.  
The sustrate mimic was 
synthesized by coupling 3,5-
dihydroxy-phenylacetic acid with amino-CoA.  To prepare 3,5-dihydroxy-phenylacetic 
acid, methyl 3,5-dihydroxyphenylacetate (150 mg, 0.823 mmol) was added to 5.0 mL of 
2 M aqueous NaOH and stirred at room temperature.  After gentle shaking for 1.5 hr, the 
reaction was acidified to pH 1.0 with 2 M HCl.  The resulting orange solution was flash 
frozen and lyophilized. A red-orange powder was obtained and taken up in MeOH and 
passed through a plug of silica gel.  Concentration in vacuo gave 3,5-dihydroxy-
phenylaceitc acid as a white poweder (110 mg, yield 80%). 
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The coupling of 3,5-dihydroxy-phenylacetic acid and amino-CoA was done 
following the published procedure for the synthesis of acyl amino acid coenzyme A 
thioester,29 with two modification:  2.5 eq. of 3,5-dihydroxy-phenylacetic acid and 2.5 eq. 
of PyBOP were used to couple 9.0 mg of amino-CoA.  The crude product was purified by 
preparative HPLC using the following gradient:  8 mL/min; 0-3 min, 0% B; 3-40 min 0-
20% B, where A=0.1% TFA/H2O; B=CH3CN; Dpa-NH-CoA eluted at 222 min, 
monitoring at 260 nm.  After lyophilizing, Dpa-NH-CoA was recovered as a white 
powder (10.3 mg, yield 95%).  1H NMR (D2O, 400 MHz) δ 8.71 (s, 1H), 8.45 (2, 1H), 
6.31 (overlapping m, 2H), 6.24 (overlapping m , 2H), 4.93 (overlapping m, 2H), 4.66 (br 
s, 1H), 4.34 (br s, 2H), 4.07 (s, 1H), 3.92-3.90 (m, 1H), 3.69-3.67 (m, 1H), 3.44 
(overlapping m, 4H), 3.33 (overlapping m, 4H), 2,42 (t, J = 6.0 Hz, 2H), 0.99 (s, 3H), 
0.89 (s, 3H).  13C NMR (D2O, 126 MHz) δ 174.9, 174.8, 174.3, 157.1 150.0, 148.6, 
144.8, 142.7, 137.7, 118.8, 108.3, 101.5, 87.8, 83.8, 74.6, 74.3, 74.2, 72.1, 65.3, 42.5, 
38.9, 38.8, 38.6, 35.6, 21.0, 18.8.  31P NMR (D2O, 121 MHz) δ 0.74, -9.90, -10.34.  
HRMS (ESI-) m/z Calcd for C29H42N8O19P3 899.1779, found 899.1825. 
 
Crystallographic studies of DpgC with the substrate mimic Dpa-NH-CoA15 
 
Crystallization of DpgC with Dpa-NH-CoA.  Elisha Fielding established crystallization 
conditions for DpgC bound to Dpa-NH-CoA.  DpgC (12 mg/mL) was incubated with 
Dpa-NH-CoA (2 mM) at 20oC for 2 hr.  Crystallization conditions were determined by 
screening the enzyme small molecule mixture against the Hampton Research Crystal 
Screens I and II (Hampton).  The co-complex crystallized in 100 mM sodium citrate, 165 
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mM ammonium acetate and 24% (w/v) PEG 4000, pH 5.6.  The DpgC/substrate mimic 
complex (1.5 µL) was mixed with 1.5 µL of the crystallization solution.  Crystals 
typically appeared after 2 days.  Crystals were transferred to a cryoprotectant solution, 
consisting of crystallization solution with 20% glycerol, then were flash frozen in liquid 
N2.   
 
Structure determination.  Phase information for the co-complex structure was 
calculated with the molecular replacement program AMORE using the incomplete native 
structure as the search model.  The model was built with the program COOT30 and 
refined with the software suite CNS.31  Initial structural refinement was performed with 
non-crystallographic (NCS) restraints.  After several rounds, the restraints were removed 
from calculations.  Sigma-weighted simulated annealing composite omit maps were used 
to build the model.  The Matthews coefficient indicated two trimers present in the 
asymmetric unit.  Due to an anomaly in the crystal, only one trimer was completed.  This 
anomaly is discussed earlier in the chapter.   
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Table 3:  Crystallography data collect and refinement statistics 
Data collection  DpgC/Dpa-NH-CoA complex 
Space group   P21212 
Cell dimensions 
 a, b, c (Å)  139.9, 156.7, 171.0 
 α, β, γ, (o)  90, 90, 90 
Wavelength   1.000001 
Resolution (Å)  2.40 
Rsym or Rmerge   0.130 (0.577) 
I/σI    15.46 (2.55) 
Completeness (%)  98.0 (96.7) 
Redundancy   5.1 (4.4) 
Refinement 
Resolution (Å)  2.45 
No. reflections  128559 
Rwork/ Rfree   0.328/0.356 
No. atoms 
 Protein   9797 
 Ligand/ion  180 
 Water   225 
B-factors 
 Protein   38.82 
 Ligand/ion  42.84 
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 Water   32.83 
R.m.s. deviations 
 Bond lengths (Å) 0.008 
 Bond angles (o) 1.4827 
*Highest resolution shell is shown in paranthesis. 
 
Kinetic studies of DpgC mutants and alternate substrates.  Ye Liu determined kinetic 
parameters of Dpa-NH-CoA.11 Elisha Fielding carried out all kinetic studies on DpgC 
mutants Arg254Lys, Glu189Gln, Glu255Gln and Gln299Asn; as well as all DpgC 
alternate substrate assays.22   
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Chapter 4:  Probing the oxygen-binding pocket of DpgC. 
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Introduction 
 The way in which cofactor-independent oxygenases bind molecular oxygen has 
been an area of speculation for quite some time.1 The presence of a hydrophobic pocket 
in or adjacent to the active site has been suggested as a structural motif for a cofactor-
independent oxygenase to bind molecular oxygen for catalysis.  Alternatively, it has also 
been suggested that molecular oxygen in solution could come into close enough 
proximity to the substrate for activation, negating the requirement for a specific oxygen-
binding region.1   
The enzyme DpgC from the vancomycin biosynthetic pathway is a cofactor-
independent dioxygenase, which uses a hydrophobic pocket to bind molecular oxygen.  
Our structural 
characterization 
of DpgC 
showed electron 
density 
consistent in 
size and shape 
to molecular 
oxygen in a 
hydrophobic pocket adjacent to the active site of the enzyme.2 DpgC uses this 
hydrophobic pocket to bind molecular oxygen and catalyze a four electron oxidation and 
thioester cleavage.3   
Figure 1:  Reaction catalyzed by DpgC 
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In the case of several metal-containing enzymes, a hydrophobic pocket off the 
metal center has been suggested as responsible for initial oxygen binding.  This 
hydrophobic pocket has 
been discussed in the 
examples of bovine 
serum amine oxidase 
and tyrosine 
hydroxylase.4,5  Crystallographic evidence for an oxygen-binding region in flavin 
dependent enzymes has also been demonstrated.6 
Two recent crystal structures of flavin-dependent enzymes with oxygen bound 
adjacent to the flavin cofactor have been reported. Eswaramoorthy et al. solved the 
structure of a flavin containing 
monooxygenase (FMO) from S. pombe.7 
The authors describe an “electron density 
feature” present in the active site that is 
consistent with a bound oxygen molecule.  
The location of the proposed molecular 
oxygen molecule makes it available to 
form a 4Α-hydroxyflavin species (Figure 
2).  Although molecular oxygen is a non-
polar species, the authors suggest that it that forms a hydrogen bonding contact with 
Asn91. The presence of molecular oxygen in the crystal structure led the authors to 
Figure 2:  Activated flavin species used by flavin monooxygenase 
Figure 3:  Active site of flavin monooxygenase.  
PDB code:  1VQW 
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propose that Asn91 orients oxygen for reaction with flavin and may stabilize the 
peroxyanion intermediate.  
The area in which molecular oxygen is bound in the FMO structure is not 
particularly hydrophobic.  Aside from Asn91, residues in proximity to the modeled O2 
molecule are Thr92, Trp434, Pro342, and the carbonyl oxygen of Val340.  The predicted 
oxygen-binding region is widely accessible to solvent.  The closest contacts the oxygen 
molecule makes are between ND2 of Asn91, 3.26 Å to atom O1, C4A of flavin and O1, 
3.57 Å, and the carbonyl of Val340 and O2 of molecular oxygen, 3.26 Å.  
Eswaramoorthy et al. suggest Asn91 is the most catalytically relevant residue as few 
other residues could be involved in binding and stabilizing molecular oxygen for 
downstream chemistry.  The flavin cofactor plays the largest role in oxygen binding by 
providing a fairly hydrophobic environment.   
The second example of oxygen bound to a flavin dependent enzyme comes from 
vitamin B12 biosynthesis.  The enzyme BluB catalyzes the conversion of flavin 
mononucleotide to 5,6-dimethylbenzimidazole 
(Figure 4).  The Walker lab solved the structure of 
BluB bound to reduced flavin.6 The use of flavin as a 
cofactor and substrate is unusual and prompted the 
authors to name a new family after this enzyme: 
“flavin destructase.”  The authors observe electron 
density consistent with molecular oxygen located over the reduced flavin.  As in the case 
of DpgC bound to the substrate mimic Dpa-NH-CoA, molecular oxygen is bound to the 
enzyme poised to react.  Unlike DpgC, the oxygen bound to BluB is tightly held in a 
 
Figure 4:  Chemistry of the “flavin 
destructase” BluB 
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pocket inaccessible to the solvent (Figure 4).  Oxygen in the BluB structure makes two 
hydrogen bonds with the O2’ hydroxyl of FMN and with the backbone amide of Gly61.  
This interaction is suggested to be a “peroxyanion hole.”  The authors suggest that this 
structural motif is shared by flavin monooxygenases as a way of binding molecular 
oxygen, and possibly stabilizing a peroxy-intermediate.  The peroxyanion hole in BluB is 
dependent on the conformation of the ribityl tail of FMN.8,9  In the case of BluB, the 
ribityl tail conformation resembles that of flavin oxidoreductases not monooxygenases.  
BluB has conformational similarity to oxidoreductases and functional similarity to 
monooxygenases.   
The oxygen-binding region of BluB is quite different from that of the FMO 
(Figure 3).  BluB provides a richly hydrophobic environment with very little access to 
solvent.  The binding pocket is formed by two monomers of BluB (Figure 5).  Residues 
Figure 5:  The active site of BluB is at the interface between two monomers.  On the left, a surface 
representation depicting molecular oxygen and flavin buried between two monomers (monomer A in 
yellow, monomer B in blue).  A view of the active site showing the peroxyanion hole and several 
residues responsible for creating the tight, hydrophobic pocket.  PDB code:  2ISL  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Ile168, Leu204, Leu106, Trp209 and Leu108 from one monomer and Leu132 from the 
second monomer create this tight binding pocket in which FMN cradles O2.  The 
suggested peroxyanion hole is the only component of the pocket that is hydrophilic.    
The crystals of BluB with reduced flavin disintegrate over time; implying that catalysis 
causes a structural rearrangement that disrupts the crystal lattice.  A significant 
conformational change would have to occur for FMN to bind the enzyme as the 
catalytically relevant conformation would not allow diffusion of the flavin cofactor into 
the active site. 
As will be discussed in this chapter, the oxygen-binding pocket of DpgC shares 
aspects of the FMO and BluB binding pockets.  Similar to BluB, DpgC has a 
hydrophobic pocket believed to bind molecular oxygen.  However, the pocket is readily 
accessible to solvent as seen with FMO.  We have shown experimentally that perturbing 
the oxygen-binding pocket through mutation and biochemical characterization has 
demonstrated the importance of the hydrophobic residues to oxygen binding.  
Crystallography with a slightly altered substrate mimic demonstrated the sensitivity of 
the pocket to subtle changes in the environment. 
 
Identification of residues composing the hydrophobic pocket 
 The hydrophobic oxygen-binding pocket of DpgC resembles a basket that is open 
to solvent.2 As oxygen moves towards the site of oxidation on the substrate, the pocket 
narrows and becomes capable of binding and orienting molecular oxygen for activation 
by the substrate.  Based on the location of the electron density that is consistent with 
molecular oxygen, four residues were selected for mutagenesis to probe the oxygen-
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binding pocket.  Although these four 
residues do not comprise the entire 
oxygen-binding pocket, they are the 
closest in proximity to the modeled O2 
molecule.  Residues Ile324, Leu237, 
Val425 and Val429 were each mutated to 
a threonine to study the effect of subtle 
perturbation on the oxygen-binding 
pocket. 
 
 
Site-directed mutagenesis in the oxygen-binding pocket and kinetic analysis of 
mutant constructs 
Threonine was selected as the mutant for each of the four residues identified as 
critical in the oxygen-binding pocket.  The choice of threonine 
provided a hydrophilic component to the hydrophobic pocket 
while maintaining some hydrophobicity.  This change creates a 
subtle perturbation of the hydrophobic pocket.  We felt 
substituting serine or aspartate residues would too drastically 
affect substrate binding and cause too severe a change in the 
active site to offer any meaningful observations.  Mutant 
constructs were created using the QuikChange mutagenesis kit 
(Strategene) and were assayed for kinetic competence.  Kinetic 
Figure 6:  Surface representation of the DpgC 
oxygen-binding pocket.  Hydrophobic residues 
shown in green, molecular oxygen in red  
Figure 7:  Mutation 
strategy for perturbing 
the DpgC oxygen-
binding pocket.  
Mutating hydrophobic 
residues to threonine. 
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parameters, kcat and KM, of the hydrophobic pocket mutants were initially determined for 
the natural substrate of DpgC using the DTNB assay.10 However, to better understand the 
capability of the oxygen-binding pocket, assays were carried out on an oxygen electrode.  
By using an oxygen electrode, we observed consumption of molecular oxygen by DpgC 
during catalysis.  The rate of oxygen consumption was measured at various O2 
concentrations.  The I324T mutant had the most significant impact on substrate as well as 
oxygen kinetic parameters.  This was expected as Ile324 is closest to molecular oxygen in 
the crystal structure, 3.24 Å.  In fact, this mutant showed no turnover during kinetic 
assays with regard to oxygen.  The other three mutants also showed decreased kinetic 
competence.  This biochemical characterization corroborated our identification of the 
unassigned electron density as molecular oxygen.  Our kinetic data also indicated that we 
had identified an oxygen-binding pocket in a cofactor-independent oxygenase.   
 
Soaking co-crystals with the noble gas xenon 
 Further attempts to unequivocally assign the orphan electron density as molecular 
oxygen involved a unique crystallographic experiment.  The noble gas xenon (Xe) has 
been exploited as an isoelectronic/isosteric mimic of O2.11  The advantage of 
Table 1:  Kinetic parameters for the DpgC hydrophobic pocket mutants 
   KM (DpaCoA) kcat (DpaCoA) kcat/KM* KM (O2) 
Wild type  3.9  0.172  1.0  1.7  
Ile324Thr  >1,000  ND  ND  ND 
Leu237Thr  58.0  0.050  0.019  2.1 
Val429Thr  14.7  0.019  0.029  >2.6 
Val425Thr  13.8  0.037  0.060  2.6 
 
The units for KM(DpaCoA) are µM, kcat are in s-1 and KM (O2) are mM.  ND, not 
determined. * Apparent kcat/Km relative to the wild type enzyme  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incorporating Xe into a macromolecular crystal is the anomalous signal of Xe.  When X-
ray data are collected at the absorption edge of Xe (1.5000 Å) it is possible to observe the 
noble gas bound to the protein.  We soaked crystals of DpgC bound to the substrate 
mimic by placing them in a chamber under 300-500 psi Xe gas.  We had hoped Xe would 
displace the oxygen bound to the hydrophobic pocket.  This would be observed through 
an electron density map anomalous data, which would take the difference of the 
anomalous data from the native data, leaving only electron density for bound Xe.  The 
experiment worked in the sense that Xe bound to the enzyme and it was observe through 
the difference map.  However, we did not observe Xe bound to the assigned hydrophobic 
oxygen-binding pocket of DpgC.  Instead, Xe was observed in a hydrophobic region in 
which the noble gas displaced a Phe residue from its original conformation.  The inability 
of Xe to bind to the oxygen-binding pocket indicated to us that the pocket adjacent to the 
active site is specific for O2 and will not promiscuously bind other hydrophobic gases. 
Figure 8:  On the left, Xe bound to DpgC in the same location in each monomer.  On the right, The 
hydrophobic region of DpgC where Xe binds, displacing Phe315.  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Crystal structure of the DpgC Val425Thr mutant 
 To further observe the effect of our hydrophobic pocket mutants, we solved a 
crystal structure of one of the mutants.  The V425T mutant bound to the substrate mimic 
crystallized under similar conditions to that of the native enzyme bound to the mimic.  
The structure of the mutant was solved through molecular replacement using the structure 
of the wild-type enzyme bound to the substrate mimic (Chapter 3).  The overall structure 
of the V425T mutant is highly similar to the wild-type structure discussed in chapter 3.  
The same anomaly preventing the construction of the second trimer is also present in 
these crystals, however the quality of the electron density maps is high.  Electron density 
surrounding the substrate mimic is clear and well defined.  Dpa-NH-CoA is bound in a 
similar fashion to the wild-type.  The key difference in the structure of the V425T mutant 
Figure 9:  Electron density from composite omit map of Val425Thr mutant, on the left.  On the right, 
surface representation of Val425Thr DpgC active site, brown represents hydrophobic region, pink 
represents the area that the threonine mutant disrupts the hydrophobic region.  Red molecule shows 
oxygen position in native structure.  RMSD between native and V425T = 0.6814 Å 
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is the lack of electron density in the position of the predicted bound molecular oxygen.  
All three trimers show no clear electron density in the location of molecular oxygen 
observed in the native structure.  This corroborates the assignment of the orphan electron 
density in the native structure as molecular oxygen.  Val425 is significantly far from the 
substrate-binding portion of the enzyme (5.89 Å).  This mutant represents a subtle 
perturbation of the hydrophobic pocket, which based on the crystallographic data from 
V425T, is significant enough to prevent binding of molecular oxygen to DpgC crystals.   
 
Synthesis and crystallization of a Dpa-fluoro-NH-CoA inhibitor 
 Once the starting complex of DpgC and the substrate mimic Dpa-NH-CoA was 
established, we designed a new mechanistic inhibitor.  It was hoped that this new 
inhibitor would provide evidence for the next step in the reaction mechanism of DpgC.  It 
was established through biochemical work on DpgC that the substrate goes through an 
enolate intermediate.3 This intermediate is common to the crotonase superfamily,12 so we 
hoped to observe an enolate intermediate bound to DpgC in a crystal structure.  Since the 
hydrogens at the α−C position of Dpa-NH-CoA are too basic to be deprotonated by 
DpgC, we set about trying to lower the pKa at that position.  Our strategy was to 
introduce a fluorine at the α−C position.  We predicted the electronegative fluorine atom 
would lower the pKa of the remaining proton to allow deprotonation and observation of a 
bound enolate intermediate.   
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 Synthesis of Dpa-α−fluoro-NH-CoA involved synthesizing amino-CoA as 
described in chapter 3.  The fluorine is installed through chemistry outlined in Figure 10.  
After protection of 
methyl-3,5-
dihydroxyphenylacetate, 
a regioselective 
bromination at the α−C 
position is carried out 
with N-
bromosuccinimide.  
Bromine is then 
displaced to give a 
hydroxyl at the α-C position in a two-step protocol, which is then fluorinated with the 
DAST reagent.  After deprotection, the acid is coupled to amino-CoA with PyBOP. 
 With the newly synthesized inhibitor in hand, crystallographic and biochemical 
characterization were carried out.  Dpa-fluoro-NH-CoA proved to be an inhibitor with 
comparable kinetic parameters to Dpa-NH-CoA (Figure 10).  However, assays with 
DpgC revealed that Dpa-fluoro-NH-CoA did not form an enolate intermediate.  An NMR 
assay carried out in D2O 
was expected to show the 
disappearance of the 
proton geminal to the 
fluorine (Figure 11).  This result was not observed.  In spite of its inability to form an 
Figure 11:  Assay used to biochemically determine formation of 
enolate by DpgC and Dpa-fluoro-AmCoA  
Figure 10:  a.  Bz-Cl, Et3N, DCM. b. NBS, CCl4. c. (i) NaOAc, 2:1 
NMP:H2O. (ii) HCl, MeOH. d. DAST, DCM. e. KOH, MeOH. f. 
PyBOP, DIPEA, 4:1 NMP:H2O.  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enolate, the protein crystal structure of DpgC in complex with Dpa-fluoro-NH-CoA 
provided an interesting result. 
 The electron density for molecular oxygen was not observed in this new complex.  
DpgC and Dpa-fluoro-NH-CoA crystallized under similar conditions and in the same 
space group as DpgC bound to Dpa-NH-CoA.  The structures of DpgC bound to each 
inhibitor are largely the same (RMSD), and electron density in the active site shows 
similar conformations for all residues.  The major difference is the absence of molecular 
oxygen bound to the protein.  Another notable difference is the absence of the water 
network anchored by Gln299. 
 The introduction of an electronegative fluorine atom perturbed the active site 
enough to prevent the binding of molecular oxygen to an otherwise identical system.  The 
absence of molecular oxygen bound to the active shows the sensitivity of the binding 
pocket to minor changes. 
Figure 12:  On the left composite omit electron density in the DpgC active site/oxygen-binding pocket.  
On the right, A surface representation of the DpgC oxygen-binding pocket, with hydrophobic residues 
in green.  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An artificial peroxyanion hole in the structure of DpgC bound to Dpa-NH-CoA 
 As discussed in the introduction of this chapter, a structural motif called a 
peroxyanion hole has been implicated in binding molecular oxygen by proteins.6 A 
peroxyanion hole functions in a similar fashion to an oxyanion hole.  Protons from 
amides or alcohols act as hydrogen bond 
donors to an electron rich species.  
Arginine and asparagine residues have 
also been suggested as components of 
peroxyanion holes.  In the case of 
oxygenases, molecular oxygen is the 
electronegative species that accepts 
hydrogen bonds from the enzyme and/or 
cofactor.  While the molecular oxygen 
electron density in DpgC is found in a 
hydrophobic region of the enzyme, there are two hydrophilic components adjacent to the 
O2 molecule.  The backbone amide of Ile324 makes a hydrogen bond, 3.07 Å, to the 
bound molecular oxygen.  The amide in the substrate mimic is also within hydrogen 
bonding distance, 3.10 Å, to molecular oxygen (Figure 13).  These hydrogen bonds are 
oriented on either side of the observed electron density.  Therefore it is reasonable to call 
this structural motif a peroxyanion hole.   
The importance of this motif in terms of our crystallographic work is evident 
when considering DpgC’s molecular oxygen binding constant (KM(O2)).  The ambient 
Figure 13:  Peroxyanion hole formed by the 
substrate mimic Dpa-NH-CoA and backbone 
amide of Ile324.  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concentration of molecular oxygen in aqueous solution is 0.25 mM, while the KM(O2) of 
DpgC is 1.7 mM.  The fact that DpgC has a higher KM than the concentration of O2 
makes the presence of molecular oxygen in the crystal structure unlikely without the help 
of the peroxyanion hole formed by Ile324 and the substrate mimic.  From this fortuitous 
interaction, we were able to learn a great deal about the structural elements of DpgC that 
allow it to perform this fascinating chemistry. 
 
The path of molecular oxygen in DpgC:  Can we elucidate superoxide and carbon-
oxygen bond formation by DpgC? 
 Our biochemical and crystallographic evidence support the claim that native 
DpgC bound to Dpa-NH-CoA shows electron density consistent with molecular oxygen.  
This evidence also supports the identification of a hydrophobic pocket responsible for the 
binding of molecular oxygen and its preparation for downstream chemistry.  However, 
several issues remain unanswered in regard to the oxygen-binding pocket and more data 
needs to be collected regarding activation of molecular oxygen to superoxide.  While our 
data indicate that the hydrophobic pocket discussed above is crucial to oxygen binding, 
some aspects of the DpgC crystal structure point toward other hydrophobic regions as 
being involved in oxygen binding and activation (Figure 14).   
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Figure 14:  Possible paths of molecular oxygen in the DpgC active site.  The solid red oxygen molecule 
is observed in the native structure bound to Dpa-NH-CoA.  O2* indicates possible positions of 
molecular oxygen prior to reduction by the substrate.  Area below, shown bottom left, and above, 
shown bottom right, offer environments suitable for molecular oxygen binding and stabilization of 
superoxide and a peroxy-substrate intermediate (Figure 15).  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 Crystal structures of flavin dependent oxygenases and cofactor-independent 
oxygenases present structure features that are believed to stabilize the formation of 
superoxide and organo-peroxy intermediates.13,14  The conformation of molecular oxygen 
and the substrate mimic shown in the native crystal structure could represent the complex 
immediately before superoxide reduction.  The hydrogen bond formed between 
molecular oxygen and the backbone amide of Ile324 presents a possible stabilizing 
interaction for superoxide and a possible peroxy-substrate intermediate.  There are two 
 
Figure 15:  Proposed mechanism for DpgC: highlighted is a peroxy intermediate stabilized by a 
glutamine residue.  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Figure 16:  Alignment of five DpgC sequences from vancomycin family biosynthetic pathways.  The first 
listed is the structure solved by Bruner lab.  Highlighted in green are residues identified as a hydrophobic 
binding pocket from DpgC bound to Dpa-NH-CoA (Figure 5).  Highlighted in cyan are residues in a 
hydrophobic pocket on the si face of the dihydroxyphenyl ring of the substrate.  Highlighted in yellow are 
residues in a hydrophobic pocket on the re face of the dihydroxyphenyl ring of the substrate.  Highlighted in 
red are glutamine residues found in the re and si hydrophobic pockets.  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other possible locations for molecular oxygen to migrate to before being reduced by the 
substrate (Figure 14).  These locations include hydrophobic regions on either side of the 
substrate phenyl ring.  The pocket on the si face of the ring is lined with residues Ile235, 
Leu240, Ile235, Phe250, Ile324 and Phe250.  This region is almost entirely made up of 
hydrophobic residues except for Gln416.  If molecular oxygen were to bind in this 
pocket, it would be ideally situated to undergo single electron reduction from the electron 
rich ring of the substrate.  The presence of Gln416 could offer some stabilization of a 
peroxo-intermediate (Figure 16).  The re face of the substrate phenyl ring is adjacent to 
Gln299, which anchors the water network responsible for deprotonation of the C2 
position on the substrate.  The residues surrounding Gln299 are hydrophobic, which are 
hospitable for molecular oxygen migration.  If oxygen were reduced to superoxide at this 
location, Gln299 would serve as a stabilizing residue for superoxide and the peroxy 
intermediate.  The geometry between the substrate and Gln299 is well suited for this type 
of interaction.  Further research is required to test the possibility of oxygen migration 
from its current position in the native bound structure to a position on either side of the 
substrate phenyl ring.  The residues in the hydrophobic regions on either side of the 
substrate phenyl ring are conserved in all DpgC homologues. 
 Establishing how DpgC facilitates a single-electron transfer from the substrate to 
molecular oxygen and how a peroxy-intermediate and a possible dioxetanone 
intermediate are formed and stabilized are key questions that must be answered to fully 
understand the mechanism of this enzyme. 
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Materials and Methods 
Mutagenesis.  Point mutations of DpgC were made using the QuikChange Multi Site-
Directed Mutagenesis Kit ( Stratagene: La Jolla, CA).  Elisha Fielding carried out the 
hydrophobic pocket mutagenesis work.  The procedure is detailed in published material.2  
DpgC substrate kinetic parameters. Elisha Fielding carried out substrate kinetic 
parameter measurements.  Kinetic parameters of the DpgC active site mutants were 
analyzed using the DTNB reporter assay as described above with one modification: the 
concentration of the DpgC mutant was 0.186 µM. 
Measurement of kinetic parameters for dioxygen.  All enzymes were prepared for 
assays using the procedure described above.  O2 consumption was measured using a 
Clark-type O2 electrode (Hansatech Instruments) and the electrode signal was recorded 
using Virtual Bench Data Logger.  The electrode was calibrated using the 2,3-
dihydroxybiphenyl and DHBD.15 Data was collected every 0.003 s and initial velocities 
were determined from progress curves (Microsoft Excel).  Steady-state rate equations 
were fir to data using the least squares and dynamic weighting options of LEONORA.16 
The kinetic parameters of DpgC with respect to O2 were determined in 100 µM Dpa-CoA 
and varying concentrations of O2.  Reaction buffers (20 mM TrisHCl, 50 mM NaCl, pH 
7.5) at 25oC were prepared by bubbling mixtures of O2 and N2 gases for at least 5 min.  
The gases were mixed using a gas proportioner (Specialty Gas Equipment) and 
transferred to the reaction vessel using a Hamilton syringe.  The concentration of O2 was 
confirmed using the O2 electrode.  The assay was initiated by injection of enzyme (2 µM) 
into the reaction vessel containing buffer and Dpa-CoA (1 mL final volume).  The initial 
rates increased almost linearly with O2 concentration and no points above the Km could 
be obtained, causing the low precision in the kinetic parameters. 
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Xenon Crystal Derivatives.  DpcC-inhibitor co-complex crystals were placed in a 
Xenon pressure chamber (Hampton Research) for a range of 5 to 45 min with pressures 
of 300 to 500 psi.  The xenon equilibrated crystals were flash frozen within seconds of 
removal from the xenon chamber.   
 
Enzyme Production.  Overexpression and purification of DpgC and all DpgC mutants 
were carried out under conditions identical to those described in chapter 2.  
Crystallization and data collection.  Recombinant DpgC (48kDa, 438 amino acids) 
from Streptomyces toyocaensis was crystallized in the presence of Dpa-NH-CoA or Dpa-
α−fluoro-NH-CoA by the hanging drop vapor diffusion method at 20oC.  120 mL DpgC 
(12 mg/mL in 20mM Tris, 100mM NaCl, 1mM bME, pH 7.5) was mixed with 30 mL 
8.73mM Dpa-NH-CoA or Dpa-fluoro-NH-CoA and incubated for 30 min. at 4oC.  1 mL 
of this solution was added to 1 mL of reservoir solution (100mM sodium citrate, 150mM 
ammonium acetate and 12-20% PEG 4,000, pH 5.6).  Prism like crystals appeared after 
two days.  Crystals were transferred to a cryoprotectant solution of reservoir solution with 
20% glycerol, briefly soaked then flash frozen in liquid nitrogen.  X-ray diffraction data 
for DpgC bound to Dpa-fluoro-NH-CoA was collected on the X29A beamline at the 
National Synchrotron Light Source at Brookhaven National Labs on ADSC Q315r 
Crystal Logic diffractometer.  Data for DpgC Val425Thr bound to Dpa-NH-CoA was 
collected on the X12C beamline at the National Synchrotron Light Source at Brookhaven 
National Labs on an ADSC Q210 Crystal Logic diffractometer.  Data was collected at 
100o K.  Diffraction intensities were indexed, integrated and scaled with HKL2000 as 
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summarized in Table 1.  The crystal belongs to the space group P21212 with unit cell 
dimensions:  a=39.155, b=156.079, c=170.959; α, β,γ=90o. 
 
Model building, refinement and graphics.  The structures were obtained by simple 
molecular replacement with the inhibitor bound structure of DpgC (PDB code:  2NP9).  
The model was built using the program COOT.17 Refinement cycles and generation of 
2Fo-Fc and Fo-Fc composite omit maps were done using the CNS suite of programs.18 
Cycles of rigid body refinement, simulated annealing, composite omit maps and addition 
of waters into the structure was done until Rfree values were no longer improving to any 
extent.  To generate images of the structure the program Pymol was used. 
 
Table 1.  Crystallography data collection and refinement statistics  
Data Collection  Dpa-α−fluoro-NH-CoA Val425Thr 
Space Group   P21212    P21212 
Cell dimensions (Å) 
a, b, c (Å)  139.952, 156.079, 170.959 139.155,156.141,171.284 
 α, β, γ (o)  90, 90, 120   90, 90, 120 
Wavelength (Å)  1.00000   1.00000 
Resolution (Å)  2.5    2.8 
Rmerge or Rsym   0.081 (0.324)   0.138 (0.544) 
I/σI    22.9 (3.4)   18.2 (4.1) 
   
Completeness   99.2 (96.4)   98.9 (98.8) 
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Redundancy   6.1 (5.2)   7.4 (7.1) 
Refinement 
Resolution (Å)  2.5    2.8 
No. reflections   128431   91225 
Rwork/Rfree   0.336/0.362   0.339/0.344 
No. atoms   10154    9846 
B-factors   38.2    44.5 
R.M.S.D. 
 Bond lengths (Å) 0.029    0.032 
 Bond angles (o) 1.9    2.1 
 
Synthesis of Dpa-fluoro-amino-CoA 
1H NMR spectra were recorded using a Varian Unity INOVA 400 MHz (400 MHz) 
spectrometer.  Chemical shifts are reported in ppm from trimethylsilane with the solvent 
as the internal standard (CDCl3: δ 7.26 ppm, D2O:  δ 4.80 ppm).  Data are reported as 
follows:  chemical shift, (multiplicity [singlet (s), doublet (d), triplet (t), quartet (q) and 
multiplet (m)], coupling constants [Hz], and integration.  13C NMR spectra were recorded 
on a Varian Unity INOVA 400 MHz (100 MHz) spectrometer with complete proton 
decoupling.  Chemical shifts are reported with the solvent as the internal standard 
(CDCl3: δ 77.23 ppm).  High resolution mass spectrometry (MS) was performed at the 
Mass Spectrometry Facility at Boston College on a LCT ESI-MS. 
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Chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO).  
Deuterated NMR solvents were purchased from Cambridge Isotope (Andover, MA).  
Purification of intermediates was performed on silica gel 60 from VWR (West Chester, 
PA).  All work-up and purification procedures were performed in air using solvents 
purchased from Fisher Scientific (Pittsburgh, PA).   
 
Methyl-2-bromo-2-(3,5-dibenzoylphenyl)acetate(3):  To a solution 
of methyl 3,5-dihydroxyphenylacetate (0.519g, 2.84 mmol) in CH2Cl2 
(20 mL) was added diisopropylethylamine (2.1mL, 11.4 mmol) and benzoyl chloride (1.7 
mL, 11.4 mmol).  The mixture was stirred at room temperature for 16h before washing 
twice with saturated sodium bicarbonate solution (2x10mL).  The organic layer was 
separated and dried in vacuo. 
The above crude product was dissolved in 15 mL dry CCl4 followed by addition of N-
bromo-succinimide(1.2g, 6.72 mmol).  The mixture was refluxed at 80oC for 4 hours.  
The reaction was washed with water (10mL) followed by brine washes (2x10mL).  The 
reaction was purified on silica in 7:3 hexanes: ethyl acetate to give the desired product as 
a white powder(1.113g, 83.5% for 2 steps). 
1H NMR (CDCl3, 400 MHz) δ 8.195 (d, J = 9.6Hz, 4H), 7.657 (t, J = 16.4Hz 2H), 7.521 
(t, J = 16 Hz, 4H), 7.415 (s, 2H), 7.410 (s, 1H), 5.375 (s, 1H), 3.816 (s, 3H).  13C NMR 
(CDCl3 100Hz) δ 168.604, 164.849, 151.804, 138.261, 134.318, 130.647, 129.089, 
120.034, 117.293, 54.055, 45.413.  HRMS (ESI+) Calcd for C23H17O6NaBr 491.0106, 
found 491.0103. 
 
OBz
BzO O
O
Br
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Methyl-2-acetyl-2-(3,5-dibenzoylphenyl)acetate(4):  To a solution of 
3 (0.737g, 1.576 mmol) in 2:1 NMP:H2O(20mL) was added sodium 
acetate(0.280g, 2.06mmol).  The mixture was refluxed for 3 hours at 
80oC.  The reaction was quenched by addition of 1:1 ethyl acetate: water(20mL).  The 
organic layer was concentrated in vacuo and purified on silica in 7:3 hexanes: ethyl 
acetate.  The desired product was obtained as a white solid(0.490g, 1.093mmol, 69.4%) 
1H NMR (CDCl3, 400 MHz) δ 8.2 (d, J = 9.6Hz, 4H), δ 7.658 (t, J = ?, 2H), 7.526 (t, J = 
16 Hz, 4H), 7.326 (s, 2H), 7.320 (s, 1H), 5.980 (s, 1H), 3.771 (s, 3H), 2.230 (s, 3H). 13C 
NMR (CDCl3 100Hz) δ 170.133, 168.715, 164.663, 151.650, 136.3119, 134.023, 
130.368, 128.810, 118.493, 116.919, 73.670, 53.098, 20.877.  HRMS (ESI+) Calcd for 
C25H20O8Na 471.1056, found 471.1048 
 
Methyl-2-hydroxy-2-(3,5-dibenzoylphenyl)acetate(5):  Compound 4 
(227mg, 0.481mmol) was dissolved in 12mL 5:1 methanol:CH2Cl2, to 
this solution was added 2 mL concentrated HCl.  The reaction was allowed to stir at room 
temperature for 16h.  The crude product was purified on silica in 7:3 hexanes:ethyl 
acetate to yield the desired product as a clear oil (105mg, 0.245mmol, 50.9%). 
1H NMR (CDCl3, 400 MHz) δ 8.25 (d, J = 9.6Hz, 4H), δ 7.697 (t, J = 14.8, 2H), 7.566 (t, 
J = 15.6 Hz, 4H), 7.368 (s, 2H), 7.265 (s, 1H), 5.321 (d, J = 5.2, 1H), 3.793 (s, 3H). 13C 
NMR (CDCl3 100Hz) δ 173.28, 164.73, 151.52, 140.86, 133.91, 130.31, 129.26, 128.75, 
117.48, 115.93, 72.20, 53.48.  HRMS (ESI+) Calcd for C23H18O7Na  429.0950, found 
429.0944 
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Methyl-2-fluoro-2-(3,5-dibenzoylphenyl)acetate(6):  A solution of 
compound 5 (0.1816 g, 0.447 mmol) in 10 mL CH2Cl2 was cooled to 
0oC on ice.  50 µL of DAST (0.122 g, 0.7568 mmol) was added and the reaction was 
allowed to warm to room temperature.  After stirring for 2.5 hours, the reaction was 
concentrated in vacuo and purified on silica in 6:4 hexanes:ethyl acetate to give the 
desired product as a cloudy, white oil (0.384 g, 0.89 mmol, 85%).  1H NMR (CDCl3, 400 
MHz) δ 8.1955 (d, J = 10 Hz, 4H), 7.649 (t, J = 7.2 Hz, 2H), 7.526 (t, J = 16 Hz, 4H), 
7.312 (s, 2H), 7.285 (s, 1H), 5.868 (d, J = 47.2 Hz, 1H), 3.827 (s, 3H).  13C NMR (CDCl3 
100Hz) δ 164.669, 151.781, 136.694, 136.476, 134.076, 130.421, 128.847, 117.307, 
89.410, 87.539, 53.159.  HRMS (ESI+) Calcd for C23H17O6NaF 431.0907, found 
431.0893 
 
2-(3.5-dihydroxyphenyl)-2-fluoroacetic acid(7):  Compound 
6(0.0426mmol, 17.4 mg) was added to a solution of KOH (0.256 mmol, 
14.35 mg) in methanol.  The mixture refluxed for 4 hours.  Purification on reverse 
phase(C18) HPLC gave the product as an orange oil (6.4 mg, 81.01%).  HPLC buffers:  
A: 0.1% TFA in H2O; B:  Acetonitrile; gradient:  0-5% B over 50 minutes.  Product 
elutes at 35 minutes.  1H NMR (D2O, 400MHz) δ 6.55 (s, 2H), 6.432 (s, 2H), 5.689 (d, 
J=48.8, 1H).  HRMS (ESI+) Calcd for C8H6O4F 185.250, found 185.253 
 
DPA-fluoro-NH-CoA:  
Amino-CoA(4.69mmol, 
3.5mg), compound 7(16.13 
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mmol, 3.0 mg) and PyBOP (19.21 mmol, 10.0 mg) were dissolved in 665 mL 4:1 
DMF:H2O.  Diisopropylethylamine (82.1 mmol, 7.8775 mL) was then added.  The 
reaction was gently shaken at room temperature for 3h.  The reaction was concentrated in 
vacuo until dryness.  The compound was purified on HPLC using a linear gradient of 0-
30% acetonitrile over 40 min in 0.1% trifluoroacetic acid.  The product eluted at 21min, 
and gave 3.54 µmol (75.5% yield). 
1H NMR (D2O, 400 MHz) δ 8.59 (s, 1H), 8.39 (s, 1H), 6.42 (s, 2H), 6.33 (2, 1H), 6.21 
(d, 1H), 5.70 (d, J = 46.8, 1H), 4.43 (br s, 1H), 4.29 (br s, 2H), 4.01 (overlapping m, 2H) 
3.84 (m, 2H), 3.61 (m 2H), 3.35 (m 2H), 2.33 (t, J = 13.6, 2H), 0.936 (s, 3H), 0.828 (s, 
3H).  HRMS (ESI-) m/z Calcd for C29H41N8O19FP3 917.1685, found 917.1646. 
 
Kinetic Inhibition Assays with Analog 4.  Kinetic analysis for DpgC was done using 
the DTNB [5,5’-dithiobis(2-nitrobenzoic acid)] reporter assay as described10 with one 
modification: the concentration of DpgC was 0.4 µM.  To determine the kinetic 
parameters of DpgC for the substrate Dpa-CoA, a freshly prepared solution of DTNB (1 
mM), Tris·HCl (250 mM), and increasing concentrations of DPA-CoA was mixed with 
DpgC (0.4 µM) at 24 ºC (1 mL).  The reactions were monitored in a UV-Vis 
spectrophotometer (Agilent 8453. Agilent Technologies: Santa Clara, CA) at 412 nm for 
5 or 3 min. The observed initial rate of absorbance increase was converted to initial 
reaction velocity V0 (ε412nm=13,600 M-1·cm-1). 1/V0 was plotted as a function of 1/[S] in a 
Lineweaver and Burk plot.  The measured KM was 4.7 µM and the kcat was 7.8 min-1 
(similar to literature values: KM= 6 µM, kcat= 10 min-1). 4  
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Inhibition assays were performed using the same conditions as above with 
increasing concentrations of analog Dpa-fluoro-NH-CoA at a constant concentration of 
substrate Dpa-CoA ([S] = 2 µM, 10 µM and 40 µM).  1/V0 was plotted as a function of 
concentration of 11 (Figure S3) according to the method of Dixon.19,20  The Ki was 
established to be 7.876 ±0.652 µM and the plots indicate competitive inhibition.   
The relative enzyme activity (initial velocity with inhibitor over initial velocity 
without inhibitor, when [S]=5 µM) was plotted as a function of concentration of inhibitor 
4. The concentration which inhibited 50% of the enzyme activity was taken as the IC50. 
The IC50 of 4 is 5.3 µM when the substrate concentration is 5.0 µM.  
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Chapter 5:  Biochemical characterization and efforts toward structural 
characterization of a non-ribosomal peptide synthetase module from Thermobifida 
fusca.  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Introduction 
 Nonribosomal peptide (NRP) natural products are structurally diverse small 
molecules and have a variety of biological functions.  As secondary metabolites, 
nonribosomal peptides are used by bacteria and other organisms for many fundamental 
processes.1 Vancomycin is an NRP with potent antibiotic function, evolved by bacteria to 
kill competing species in the same ecological niche and used by humans to treat bacterial 
infection.2 Siderophore secondary metabolites are frequently NRP natural products, and 
used to scavenge ferric iron (Fe(OH)3) through the formation of soluble chelation 
complexes.3 NRP natural products can be adapted for a variety of biological activities; 
each of these activities can be achieved through different chemical functionalities.   
Iron is fundamental to the most basic life processes.4 In biology, reaction of 
molecular oxygen with iron is the foundation of metabolism.  Although iron is abundant 
on the earth, a major 
drawback to its use in 
biological systems is its 
virtual insolubility in 
water (ksp =10-18M).5 
Siderophores are the 
bacterial adaptation to 
the selective pressure of 
acquiring an abundant 
yet inaccessible 
element.6 Common iron 
 
Figure 1:  Siderophores containing a variety of iron binding motifs. 
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binding/chelating structural motifs in siderophores include hydroxamates, catechols, and 
α-hydroxyacids (Figure 1).  Siderophores use these structural motifs to bind FeIII, which 
forms a water-soluble complex between the siderophore and the otherwise insoluble FeIII 
molecule (Figure 2).  These complexes are then taken into the bacteria through transport 
proteins where the iron is released from the complex for use in the cell. 
The identification of new siderophores, as well as many other natural products, 
often begins with the identification of orphan biosynthetic gene clusters.7 Using 
homology searches with the primary amino acid sequence from an orphan gene cluster it 
is possible to identify the function of the gene products.  
Based on homology to known proteins, the function of an 
entire gene cluster can be hypothesized.  When applied to a 
biosynthetic pathway, this approach can lead to accurate 
identification of a natural product’s function based purely 
on the amino acid sequence of the proteins in the pathway.8 
With the hypothesized function of a small molecule, assay-guided fractionation can be 
used to isolate that small molecule from fermentation of the producing organism.  This 
process is called “genome mining” as it begins with analysis of a bacterial genome in 
order to find small molecule natural products.9,10   
Genome mining is particularly applicable to NRP natural product discovery as 
assembly-line nonribosomal peptide synthetases (NRPS) are often co-linear to their 
products.1 It is possible to identify the amino acid building blocks activated by NRPS 
systems based on the sequence of adenylation (A) domains in the assembly line.11,12 
Based on the sequence from the genome, it is possible to propose the structure of a 
 
Figure 2:  Coelichelin 
bound to iron 
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natural product without ever isolating it.  However, there are several aspects of NRP 
biosynthesis that make the structure and even the amino acid sequence of these small 
molecules unpredictable.  These aspects include uncommon amino acid incorporation and 
module skipping and repeating.13 Therefore, in spite of the predictions made through 
bioinformatic techniques, it is necessary to experimentally characterize natural products 
and biochemically characterize the enzymes that assemble natural products.  The 
structure of fuscachelin A demonstrates that the pathway to NRP natural products is 
difficult to predict based on bioinformatic analysis. 
 
Siderophore gene cluster in Thermobifida fusca 
 An orphan gene cluster in T. fusca was found to contain genes corresponding to a 
NRPS biosynthetic pathway.14 Three NRP synthetase genes designated fscGHI are 
continugous in the cluster and correspond to five peptide elongation modules.  The first 
gene, fscG, codes for a 390 kDa 
protein which contains three 
extension modules (Figure 3).  
NRPS modules are made up of 
individually folded domains 
that are connected to each other 
via linker regions.  This allows 
a single polypeptide chain to 
contain multiple adenylation (A), condensation (C) and peptidyl carrier protein (PCP) 
domains.  FscG is a protein which contains three modules each made up of a C, A and 
Figure 3:  NRPS assembly line found in the T. fusca orphan 
gene cluster 
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PCP domains.  This single protein therefore contains the function of six separate 
enzymes.  FscH is a module containing a single condensation domain, adenylation 
domain and peptidyl carrier protein.  FscI is a termination module with a C, A and PCP 
domain, and also contains a thioesterase (TE) domain.  TE domains are responsible for 
cleaving the thioester linkage between the peptide natural product and the NRPS 
assembly line, and can also have cyclization functionality.  The amino acids activated by 
these modules can be predicted based on their A domain sequence (Figure 4).11,12  
However the indication that this biosynthetic cluster encodes a siderophore came from 
three genes upstream from the fscGHI NRPS genes. 
 One of the common structural motifs found in siderophores are 2,3-
dihydroxybenzoate (2,3-Dhb) groups.  The proteins FscA, FscB and FscD are 
homologous to the well characterized catecholate biosynthetic enzymes:  isochorismate 
synthase, isochorismatase and 2,3-dihydro-Dhb dehydrogenase.15,16,17 FscC, an A domain 
Figure 4:  Specificity of each A domain in the Fsc gene cluster.  Specificity of FscI could not be 
determined before the structure of fuscachelin A was solved. 
FscC  P M P A Q G V V 
  P L P A Q G V V  (2,3-Dhb, bacillibactin) 
 
FscG1 D A D D S G C V 
  D V W N F G F V (L-Arg, nodularin) 
  D A E D L G F V (L-Arg, vanchrobactin) 
  D V A D V G A I (L-Arg, syringomycin) 
 
FscG2 D I L Q F G V I 
  D I L Q L G L I (gly, nostopeptolide A) 
 
FscG3 D I L Q V G V I 
  D I L G L G L I (gly, nostopeptolide A) 
 
FscH  D V W H I S L V 
  D V W H I S L V (L-Ser, nostopeptolide A) 
 
FscI  D M E N L G L I 
  D M E N L G L I (L-HO-Orn, coelichelin) 
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with predicted specificity for Dhb, and a dedicated aryl-carrier protein, FscF, are present 
as stand-alone domains for incorporation of Dhb as the initial building block.   
 Based on the presence of the five NRPS extension modules and FscC/F, along 
with the specificity-conferring code of the adenylation domains, a structure for the 
product of the T. fusca orphan biosynthetic 
pathway can be proposed: a pentapeptide, N-
capped with Dhb (Figure 5).  This prediction 
represents a structure unlike any other 
characterized siderophore.  However, the actual 
structure of the molecule as determined by NMR 
and mass spectrometry techniques is quite 
different.   
 
Structure elucidation of the T. fusca siderophores, the Fuscachelins 
 Eric Dimise performed structural characterization on the fuscachelin 
siderophores.18 The small 
molecules were isolated 
from T. fusca preps 
grown in iron-depleted 
Hagerdal media.19 
Siderophore activity was 
monitored by the chrome 
Figure 5:  Predicted structure of 
fuscachelin based on the gene cluster 
sequence 
Figure 6:  Structures of fuscachelin A/B/C as determined by NMR and 
mass spectrometry. 
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azurol S (CAS) assay in order to determine the presence of an iron-binding molecule.20 
The CAS assay allowed for identification of siderophore containing fractions during 
purification.  Once pure, the fuscachelin molecules were structurally characterized 
through a series of NMR and mass spectrometry techniques (Figure 7).18 Fuscachelin A is 
a heterodimer with a macrolactone at the center of the natural product.  Fuscachelin B 
and C were also isolated from T. fusca, which also had with siderophore activity, and are 
believed to be degradation products of fuscachelin A.  The structural characterization of 
fuscachelin A allowed for the biochemical characterization of the terminal NRPS module 
FscI. 
 
Biochemical characterization of the NRPS module FscI 
 In order to corroborate that the orphan biosynthetic gene cluster identified in T. 
fusca actually produces fuscahcelin A, FcsI was biochemically characterized.  The 4.0 kb 
gene for FscI was cloned from T. fusca genomic DNA into the pET30a expression vector.  
The four-domain protein was then overexpressed in E. coli to high levels and was 
purified to homogeneity as judged by SDS/PAGE analysis.  A pyrophosphate exchange 
assay of the FscI adenylation domain was used to determine the module’s amino acid 
specificity.21 The pyrophosphate A domain assay screened the twenty canonical amino 
acids as well as ornithine and L-N-ε−hydroxyorninithine (L-HOOrn) (Figure 8).  The 
Figure 7:  Pyrophosphate exchange assay:  the reaction catalyzed by adenylation domains in NRPS 
modules. (*) indicates radioactive 32P 
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results of the A domain assay show FscI has a significant preference for L-HOOrn 
(Figure 9).  This implies the flavin monooxygenase FscE hydroxylates the free amino 
acid L-ornithine, not the mature peptide.  Prior to the structure solution of the fuscachelin 
molecules, the specificity of FscI could not be determined, as L-HOOrn was not 
considered to be a candidate for activation by FscI. 
 
 
Proposed biosynthetic pathway of fuscachelin A 
 With the structure of the natural product and biochemical evidence linking its 
production to the identified gene cluster, it is possible to propose a biosynthetic pathway 
for the molecule (Figure 10).  Fuscachelin A is most likely the product of the gene cluster 
as degradation via hydrolysis under mildly basic conditions leads to formation of 
fuscachelin B.  Fuscachelin A is a heterodimer peptide composed of a tetrapeptide and 
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Figure 8:  Relative activity of FscI with various amino acids as judged by the pyrophosphate exchange 
assay. 
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pentapeptide, each capped on the N-terminus with a Dhb group.  The unusual chemistry 
of the pathway occurs at the condensation domain of FscI.  Once FscH has coupled serine 
to the peptide chain, FscI couples the tetrapeptide to the ε-nitrogen of L-HOOrn.  At this 
point we suggest a second Dhb-capped tripeptide from FscG is coupled to L-HOOrn, this 
time at the α-nitrogen.  In each coupling, the stand-alone modules of FscH or FscI must 
“dock” with FscG.  A recognition sequence is required to facilitate the docking and 
orientation between the NRPS modules. Therefore, FscG must contain a region that can 
recognize FscH and FscI and allow for coupling between thioester-tethered peptides from 
both stand-alone modules.  After the tandem coupling to the α- and ε-nitrogens of L-
HOOrn, the thioesterase domain of FscI performs a macrocyclization to form the 10-
membered depsipeptide ring of fuscachelin A.  The FscI thioesterase domain shows 
homology to the TE domain of DhbF from bacillibactin biosynthesis, which catalyzes a 
similar reaction.22 With the variety of natural products synthesized by NRPS modules, 
structural characterization of a multi-domain module would provide great insight into the 
chemistry of these systems. 
Figure 9:  Proposed biosynthetic pathway to fuscachelin A 
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Efforts towards structural characterization of FscI 
 The NRPS enzyme FscI is an ideal choice for protein crystallography as it 
originates from an organism that is a moderate thermophile.  Thermophilic bacteria 
provide proteins that are often more amenable to protein crystallography.  Possible 
explanations for enhanced thermophilic protein crystallography are increased stability 
and reduced mobility at room temperature.  This makes all NRPS modules from the 
fuscachelin pathway good candidates for crystallography.  
Several efforts towards solving the macromolecular crystal structure of FscI were 
attempted.  Deborah Mitchell was successful in her attempts to crystallize FscI, however 
she could not reproduce the crystals.  We were able to collect a full data set on an FscI 
crystal that diffracted to 3.0 Å.  Phase information for FscI was sought after using 
molecular replacement techniques.  Crystal structures of condensation, adenylation, 
peptidyl carrier protein and thioesterase domains have been previously solved.23,24,25,26  
Therefore homology models of the four domains that compose FscI are available for 
molecular replacement.  In the case of a multi-domain enzyme, solving a structure with 
molecule replacement can be difficult.  Initial attempts towards a solution with molecular 
replacement were unsuccessful.   
The next strategy used to solve the structure of FscI was crystallization of a 
seleno-methionine (SeMet) derivative.  SeMet FscI would not crystallize under the 
original native conditions, or when screened against the Hampton Research High-
Throughput Screen, this lead to another effort of molecular replacement. 
The program PHASER provided some hope that the structure of FscI could be 
solved.27 Using the original data set from Deborah Mitchell’s crystal, multiple domains 
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were used as search models in a single search.  This is made possible by multiple 
“ensembles” used as search models in PHASER.  An ensemble is simply a protein 
structure, or multiple homologous protein structures overlaid on each other.  Initial results 
from the model searches with PHASER gave promising results.  Statistics were high 
enough to indicate a solution had been achieved.  However, no solutions from PHASER 
provided phase information for the FscI data set.   
The structure of a terminal NRPS domain was recently published, which 
contained four domains homologous to FscI.28 Current and future efforts will use this 
structure as a search model to find a phase solution for FscI.     
 
Conclusion 
 Fuscachelin A was discovered through a genome mining approach.  The proposed 
biosynthetic pathway contains unusual aspects that demonstrate the flexibility of NRP 
assembly line chemistry.  The biochemical characterization of FscI shows the importance 
of experimental evidence for determining enzyme substrate specificity.  The power of 
bioinformatic predictions will increase with experimental characterization of biological 
systems.  
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Materials and Methods 
 
Cloning, Expression, and Purification of FscI. 
The gene for fscI was amplified by using PCR from T. fusca genomic DNA with the 
following primers: 5′-GCG GAA TTC ACC ACC GCA GCC GCG GGT (EcoRI), 5′-
GCG AAG CTT CTA GCT GTG TCC GGA TCG (HindIII). The PCR products were 
purified through agarose gel electrophoresis and gel extraction (Qiagen) and cleaved with 
the EcoRI and HindIII restriction endonucleases. The fscI gene was then ligated into the 
plasmid pET30a. The plasmid was transformed into E. coli BL21(DE3) cells for gene 
expression. Cultures (1 L) were grown to A600 = 0.5–0.7 at 37 °C, at which point the 
shaker was cooled to 18 °C, and overexpression was initiated by the addition of 50 µM 
IPTG. Cultures were continued for 18 h and were harvested by centrifugation, followed 
by resuspension in 500 mM NaCl, 20 mM Tris·HCl (pH 7.5) and lysed by passage 
through a French pressure cell at 1,000 psi. Lysate was centrifuged at 10,000 rpm for 20 
min in a Beckman Coulter J2-HS centrifuge. The supernatant was incubated for 1 h with 
1 ml of metal-affinity resin (Talon resin; Clontech). Resin was washed with 4 × 10 ml of 
500 mM NaCl, 20 mM Tris·HCl (pH 7.5), and protein was eluted with 2 × 10 ml of 500 
mM NaCl, 20 mM Tris·HCl (pH 7.5), 250 mM imidazole. Protein was dialyzed against 
100 mM NaCl, 20 mM Tris·HCl (pH 7.5), 1 mM β-mercaptoethanol, 10% (vol/vol) 
glycerol, concentrated to 17 µM, and flash frozen. 
 
Pyrophosphate Exchange Assay. 
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Amino acid-dependent ATP-sodium pyrophosphate assays were performed as follows. A 
100 µl reaction contained 75 mM Tris·HCl (pH 8.0), 10 mM MgCl2, 5 mM DTT, 5 mM 
ATP, 1 mM Na432P2O7, 100 µg/mL BSA, 1 mM amino acid, 2 µM FscI. Reactions 
were initiated by addition of enzyme and incubated at 30 °C for 0.5 h. The reaction was 
quenched by the addition of 500 µl of 3.5% charcoal, 1.6% perchloric acid, 200 mM 
Na4P2O7. The charcoal was centrifuged and resuspended twice with 500 µl of 1.6% 
perchloric acid, 200 mM Na4P2O7. After washing, the charcoal was mixed with 3 ml of 
scintillation fluid and read by a Beckman–Coulter LS 6500 scintillation counter. All 
reactions were performed in triplicate. 
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Appendix:  Complex oxidation chemistry in the biosynthetic pathways to 
vancomycin antibiotics. 
Adapted from an invited review by P.F. Widboom and S.D. Bruner to be published in 
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Introduction 
Studying natural product biosynthesis often leads to the discovery of unique and 
powerful enzymes behind the biological assembly of small molecules.1 Several 
interesting oxidation enzymes are found in the vancomycin biosynthetic pathway.  The 
study of these enzymes through genetic, biochemical and X-ray crystallographic analysis 
has illuminated their role in the biosynthesis of vancomycin, and the mechanistic details 
of powerful oxidation chemistry.  In this appendix, three diverse examples of oxidation 
chemistry involved in different aspects of vancomycin biosynthesis are discussed.   
A growing understanding of all aspects of vancomycin biosynthesis expands our 
knowledge of powerful chemistry found in nature.  It also leads to the manipulation these 
systems towards the goal of combinatorial biosynthesis, which will allow for the facile 
creation of potential analogs to overcome resistance.2 
 
The non-heme iron dioxygenase, HmaS. 
 Natural products of the vancomycin family contain the amino acid L-4-
hydroxyphenylglycine (Hpg), which is always a partner in aryl/aryl and aryl ether 
crosslinks found in the mature natural 
products.1 Isotope labelling experiments 
provided the first Insights into the biosynthetic 
pathway to Hpg by establishing that Hpg is 
derived from L-tyrosine as shown in Figure 
2A.3 The first enzyme in the pathway to 4-Hpg 
is hydroxymandelic acid synthase (HmaS), 
Figure 1:  Vancomycin with 4-Hpg highlighted 
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which performs an oxidative decarboxylation/hydroxylation of the substrate 4-
hydroxyphenylpyruvate, an intermediate in the shikimic acid primary metabolic pathway.  
Several gene clusters in the vancomycin family contain a gene for prephenate 
dehydrogenase responsible for the conversion of prepenate to 4-hydroxyphenylpyruvate 
initiating the cyclic pathway to Hpg.1 The product of HmaS, the α-hydroxyacid 2, is 
elaborated to the amino acid through common enzyme chemistry: oxidization to an α-
ketoacid 3 by a flavin-dependent enzyme then installation of the α-amine by the PLP-
dependant aminotransferase, HpgT.  Interestingly, HpgT processes 3 to the phenylglycine 
4-Hpg using L-Tyr as the ammonia donor and in the process regenerates the starting α-
keto acid 1.  HpgT is same enzyme the converts DpgX to Dpg in the 3,5-
dihydroxyphenylglycine biosynthetic pathway.   
The key step in the pathway is catalyzed by the mononuclear non-heme iron 
dioxygenase, HmaS. Most characterized non-heme iron oxygenases utilize α-
Figure 2:  A.  Catalytic cycle of 4-Hpg biosynthesis.  B.  Active site of HmaS bound to  4-
hydroxyphenylpyruvate 
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ketoglutarate as a cofactor to supply reducing equivalents leading to a high-energy iron 
(oxo) species. For HmaS, this role is served by the substrate, leading to loss of carbon 
dioxide and incorporation of two oxygen atoms into the product.4 In addition, the 
hydroxylation step is unique to HmaS as the hydroxylation is selectively at the benzyl 
position as opposed to other known 4-hydroxyphenylpyruvate dioxygenases, which 
hydroxylates the phenyl ring.5 Two groups described the selectivity and reactivity of 
HmaS concurrently.6,7  Prior to this work, none of the intermediates along the pathway to 
Hpg had been identified.  An examination of the biosynthetic gene cluster for the 
vancomycin homolog chloroeremomycin revealed one gene product with high sequence 
homology to p-hydroxyphenylpyruvate dioxygenase (HPPD).  HPPD is an α-keto acid-
dependent non-heme iron-dependent dioxygenase that catalyzes the decarboxylation/ 
hydroxylation at the aromatic ring of the phenylpyruvate substrate 1. Biochemical 
experiments confirmed that the chemistry of HmaS proceeds with novel regioselectivity 
for a p-phenylpyruvate dioxygenase forming 4-hydroxymandelate (2).   The chemistry of 
HmaS is predicted to proceed analogously to other non-heme iron enzymes and is 
summarized in Figure 3.   The substrate binds as a bidentate complex with the enzyme 
chelated iron.  O2 then coordinates to the iron and adds into the α-keto group of the 
substrate.  A rearrangement results in loss of carbon dioxide and generation of a reactive 
Figure 3:  Proposed mechanism of HmaS 
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iron-oxo species.   This high-energy intermediate is capable of abstracting a hydrogen 
atom from the benzyllic position of the substrate. 
The Solomon group explored this difference in reactivity through spectroscopic 
and computational studies.8 This study showed that HPPD and HmaS have similar 
substrate bound complexes.  Spectroscopic data show comparable electronic structures 
for the active site and the iron-oxo intermediates.  This leaves the difference in 
hydroxylation selectivity to the orientation of the substrate’s aromatic ring in the active 
site.  According to structural data, two phenylalanine residues, Phe337 and Phe341, in 
HPPD play a key role in π-stacking with the substrate.9,10  Mutation Phe337 to Ile in 
HPPD confers some HmaS function, confirming the importance of substrate phenyl ring 
orientation in hydroxylation specificity.11 
Brownlee et al. recently solved the crystal structure of HmaS bound to its product 
p-hydroxymandelate.12 The crystal structure of HmaS shows the product chelated to the 
iron center through the benzylic alcohol and the carboxyl group.  The shape of the 
hydrophobic pocket found in HmaS and HPPD dictates reaction specificity.  HPPD has a 
larger hydrophobic pocket allowing differently shaped structures to evolve along the 
reaction pathway.  The tighter contour of the HmaS structure does not allow this 
movement and restricts hydroxylation to the benzyl position, creating a product similar in 
shape to the substrate.   
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The biosynthesis of β-hydroxytyrosine 
 Tyrosine residues hydroxylated at the β-position are key building blocks of the 
vancomycin family members.  These residues are partners in aryl-ether and aryl-aryl 
crosslinks with Hpg.  In a subset of the vancomycin family the hydroxyl acts as scaffold 
for the attachment of sugar moieties.  The chemistry of the hydroxylation has not been 
reconstituted biochemically but can be inferred from well-characterized systems.13 The 
pathway involves three enzymes 
with one enzyme containing a 
distinct carrier domain.14 This path 
represents a considerable amount of 
protein-based machinery to 
accomplish an overall insertion of 
one oxygen atom into L-Tyr. The 
first step involves activation and 
loading of L-Tyr by CepK (gene 
nomenclature is from the 
chloroeremomycin pathway), a 
didomain protein containing an 
adenylation domain that uses ATP 
to activate L-Tyr and load it as a phosphopantethienyl thioester on to the PCP carrier 
domain (Figure 4).  The hydroxylation then occurs on the CepK-bound L-Tyr by an iron-
heme monooxygenase of the P450 family.  The chemical mechanism of the CH activation 
and hydroxylation for the P450 family of enzyme is well established and involves an 
Figure 4:  Chemistry catalyzed by CepL, the substrate is 
tethered to a  CepK, an adenylation/PCP didomain via a 
phosphopantetheine linker 
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intermediate iron (IV) oxo species as detailed with camphor oxidase.  This results in an 
enzyme-bound (R)-β-hydroxy-(S)-tyrosine linked as a thioester.  To generate the product 
amino acid, a dedicated thioesterase (CepJ) hydrolytically cleaves the intermediate.   
 
Aryl-aryl and aryl ether crosslinking enzymes 
The oxidative crosslinks between aromatic residues on vancomycin create the 
rigid cup-like shape that gives the antibiotic its potency.  Understanding the order of 
cyclization steps and substrate specificity of the cross-linking enzymes is key toward 
understanding the development of vancomycin analogues. 
The order of aryl cyclization was first elucidated through analysis of A. 
Mediterranei knockout strains.15 Upon fermentation of an oxyA knockout construct, a 
monocyclic heptapeptide vancomycin precursor was isolated.  This showed the ability of 
either oxyB or oxyC to 
cyclize the C-O-D ring 
system.  Mutant replacement 
strains of A. Mediterranei 
knocking out oxyB and oxyC 
were also created and their 
culture filtrates analyzed to 
determine the order of 
cyclization steps.16 The oxyB knockout strain showed no cyclization product, implying 
OxyB as the initial cyclization enzyme (Figure 5).  As discussed earlier the oxyA 
knockout gave a monocyclized product, implying it to be the second cyclizing enzyme.  
Figure 5:  Schematic of the order of cyclization steps by OxyA/B/C 
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The oxyC knockout strain gave a bicyclized product.  This work elucidated the order of 
oxidative crosslinking steps on the linear peptide vancomycin precursor, also showing the 
specificity of each cross-linking enzyme for a substrate with the proper degree of 
cyclization. 
X-ray crystal structures of OxyB and OxyC were solved in the hope of elucidating 
the mechanism of this important step in vancomycin biosynthesis.17,18  Both structures 
revealed a typical cytochrome P450 fold.  However a striking difference between 
OxyB/C and other P450 enzymes is an 
exposed active site.  This open 
conformation might allow for a hexa- or 
heptapeptide substrate tethered to a 
peptidyl carrier protein to have access to 
the heme center (Figure 6).  When assays 
were attempted with purified oxyB/C in 
vitro with the linear heptapeptide as a 
substrate no activity was observed.  
Incubation of the enzymes with substrate 
under crystallization conditions yielded 
diffraction quality crystals however, 
electron density for the substrate was 
never observed.  This implied the necessity of the peptide substrate to be tethered to a 
PCP domain on the NRPS assembly line in order for the formation of aryl cross links to 
occur. 
Figure 6:  Crystal Structure of OxyB with 
P450nor.  Shown in blue are helices F and G from 
Oxy B and in semi-transparent blue F and G from 
P450nor.  Helices F and G of OxyB are shifted 
relative to a common P450 fold to allow a large 
substrate access to the active site. the cross-
coupling enzyme. 
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Loading both the hepta and hexa peptide linear precursors onto an eighty-residue 
PCP domain facilitated in vitro cross-linking by OxyB.19,20 This result indicated that in 
vivo coupling chemistry of OxyA/B/C occurs when the linear peptide precursor is still 
tethered to the NRPS assembly line through a thioester linkage (Figure 8).   
To corroborate the conclusion that cross-linking occurs on the NRPS assembly 
line, deletion mutants of A. balhimycina that stall peptide formation at two different 
locations were studied.21 The dpgA knockout mutant lacked the ability to synthesize the 
final amino acid building block, 
Dpg.  The bpsC knockout mutant 
did not have a condensation domain 
for Dpg.  In spite of an incomplete 
peptide being produced in both 
mutant strains, cross-linking 
activity was still observed.  Most 
notable is the observation of a 
complete heptapeptide from the 
dpgA mutant that had undergone all 
three oxidative cyclization 
reactions.  As Dpg was not 
available in the dpgA mutant, the 
final position in the heptapeptide 
had been substituted with Hpg.  
This shows a remarkable flexibility in the NRPS system, and in the oxidative cross-
Figure 7:  Mechanism of aryl-ether cross-linking enzyme 
OxyB. 
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linking enzymes.  Without any optimization experiments the NRPS assembly line is able 
to replace an amino acid with a similar building block.  OxyC is then able to use this 
modified side chain in the oxidative aryl-aryl coupling.  These results suggest a system 
with high enough plasticity to undergo manipulation.   
 
The Robinson group has 
shown a diverse substrate scope for 
OxyB.22,23 The enzyme catalyzing 
the first cyclization step shows 
flexibility as it cyclizes a substrate 
with altered stereochemistry at the 
sixth position.  Truncated 
vancomycin peptides are also cyclized by OxyB, specifically penta- and tri- peptide 
substrates.  Pentapeptides with varying functional groups at the 1 position are also 
cyclized by OxyB.   
A better understanding of the cross-linking enzymology will allow manipulation 
of the chemical steps that create the rigid cup shape of vancomycin that is pivotal in its 
biological activity. 
 
Conclusion 
 Beginning with the isolation and characterization of the vancomycin family of 
antibiotics, a great deal has been learned about these structurally complex natural 
products.  From sequencing the gene clusters to structurally characterizing the enzymes 
Figure 8:  Chemical representation of cross-linking 
enzymes OxyA/B/C. 
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from vancomycin family pathways, a large body of work has been achieved in this field.  
In the area of oxidation chemistry interesting cases of selectivity in addition to enzymes 
that perform chemistry without the use of cofactors or metals have been illuminated. The 
study of vancomycin enzymology has expanded our knowledge of chemistry possible in 
nature.  The continuing study of systems that produce complex natural products will 
further surprise us as novel reactivity is discovered.  
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